Relevant Journal Publications

2022

  1. Aberizk K., Collins M.A., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Tsuang M.T., Woods S.W., Cannon T.D. Walker E.F. (2022) Life Event Stress and Reduced Cortical Thickness in Youth at Clinical High-Risk for Psychosis and Healthy Youths. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2022 Feb; 7(2):171-179 [Epub 2021 Apr 28]. PMID:33930604
  2. Braun A., Santesteban-Echarri O., Cadenhead K.S., Cornblatt B.A., Granholm E., Addington J. (2022) Bullying and social functioning, schemas, and beliefs among youth at clinical high risk for psychosis. Early Intervention in Psychiatry, 2022 Mar; 16(3):281-288 [Epub 2021 May 2]. PMID:33938145
  3. Zaks N., Velikonja T., Parvaz M.A., Zinberg J., Done M., Mathalon D.H., Addington J., Cadenhead K., Cannon T., Cornblatt B., McGlashan T., Perkins D., Stone W.S., Tsuang M., Walker E., Woods S.W., Keshavan M.S., Buysse D.J., Velthorst E., Bearden C.E. (2022) Sleep Disturbance in Individuals at Clinical High Risk for Psychosis. Schizophrenia Bulletin, 2022 Jan 21; 48(1):111-121 (Epub 2021 Sep 18]. PMID:34536012
  4. Worthington M.A., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Keshavan M., Mathalon D.H., McGlashan T.H., Perkins D.O., Stone W.S., Tsuang M.T., Walker E.F., Woods S.W., Cannon T.D. (2022) Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis. Schizophrenia Bulletin, 2022 Mar 1; 48(2):395-404 [Epub 2021 Sep 28]. PMID:34581405
  5. Ku B.S., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Compton M.T., Cornblatt B.A., Druss B.G., Keshavan M., Mathalon D.H., Perkins D.O., Stone W.S., Tsuang M.T., Woods S.W., Walker E.F. (In Press) The associations between area-level residential instability and gray matter volumes from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophrenia Research, 2022 Jan 20; 241:1-9. PMID:35066429
  6. Nogovitsyn N., Metzak P.D., Casseb R.F., Souza R., Harris J.K., Prati L.M., Zamyadi M., Bray S., Lebel C., Hassel S., Strother S., Goldstein B.I., Wang JL., Kennedy S.H., MacQueen G., Addington J. (2022) Cerebello-Limbic Functional Connectivity Patterns in Youth at Clinical High Risk for Psychosis. Schizophrenia Research, 2022 Jan 21; 240:220-227; PMID:35074702
  7. Braun A., Liu L., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Keshavan M.S., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Stone W.S., Tsuang M., Walker E., Woods S.W., Cannon T., Addington J. (In Press) Bullying in Clinical High Risk for Psychosis Participants from the NAPLS-3 Cohort. Social Psychiatry and Psychiatric Epidemiology, 2022 Feb 3; PMID:35113189
  8. Deng W., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., Perkins D.O., Seidman L.J., Tsuang M.T., Woods S.W., Walker E.F., Cannon T.D. (In Press) Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes. Psychological Medicine, 2022 Feb 11; 1-8. PMID:35144716
  9. Farris M.S., Braun A., Liu L., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Keshavan M.S., Mathalon D.H., McGlashan T.H., Perkins D.O., Stone W.S., Tsuang M., Walker E., Woods S.W., Cannon T., Addington J. (In Press) Longitudinal Impact of Trauma in the North American Prodrome Longitudinal Study (NAPLS-3). Early Intervention in Psychiatry, 2022 Feb 13; PMID:35152553
  10. Santesteban-Echarri O., Sandel D., Liu L., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Keshavan M., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Stone W.S., Tsuang M.T., Walker E.F., Woods S.W., Addington J. (2022) Family history of psychosis in youth at clinical high risk: A replication study. Psychiatry Research, 2022 Feb 24; 311:114480. PMID:35245743

2021

  1. Santesteban-Echarri O., MacQueen G., Goldstein B.I., Wang JL., Kennedy S.H., Bray S., Lebel C., Addington J. (2021) Personality and Risk for Serious Mental Illness. Early Intervention in Psychiatry, 2021 Feb; 15(1):133-139 [Epub 2020 Jan 7]. PMID:31910491
  2. Worthington M.A., Miklowitz D.J., O’Brien M., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Cannon T.D. (2021) Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the NAPLS2 individualized risk calculator. Early Intervention in Psychiatry, 2021 Feb; 15(1):96-103 [Epub 2020 Jan 14]. PMID:31943807
  3. Velikonja T., Velthorst E., Zinberg J., Cannon T.D., Cornblatt B.A., Perkins D.O., Cadenhead K.S., Tsuang M.T., Addington J., Woods S.W., McGlashan T., Mathalon D.H., Stone W., Keshavan M., Seidman L., Bearden C.E. (2021) Childhood trauma and cognitive functioning in individuals at Clinical High-Risk (CHR) for psychosis. Development and Psychopathology, 2021 Feb; 33(1):53-64 [Epub 2020 Jan 21]. PMID:31959269
  4. Rinne G.R., O’Brien M.P., Miklowitz D.J., Addington J., Cannon T.D. (2021) Depression, Family Interaction and Family Intervention in Adolescents at Clinical-High Risk for Psychosis. Early Intervention in Psychiatry, 2021 Apr; 15(2):360-366 [Epub 2020 Mar 30]. PMID:32232954
  5. Devoe D.J., Liu L., Cannon T.D., Cadenhead K.S., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Woods S.W., Walker E.F., Mathalon D.H., Bearden C.E., Addington J. (2021) Persistent Negative Symptoms in Youth at Clinical High Risk for Psychosis: A Longitudinal Study. Schizophrenia Research, 2021 Jan; 227:28-37 [Epub 2020 Apr 30]. PMID:32362460
  6. Cao H., Chen O.Y., McEwen S.C., Forsyth J.K., Gee D.G., Bearden C.E., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Carrión R., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Thermenos H., Tsuang M.T., van Erp T.G.M., Walker E.F., Hamann S., Anticevic A., Woods S.W., Cannon T.D. (2021) Cross-paradigm Connectivity: Reliability, Stability, and Utility. Brain Imaging and Behavior, 2021 Apr; 15(2):614-629 [Epub 2020 May 2]. PMID:32361945
  7. Woods S.W., Bearden C.E., Sabb F.W., Stone W.S., Torous J., Cornblatt B.A., Perkins D.O., Cadenhead K.S., Addington J., Powers A.R. III, Mathalon D.H., Calkins M.E., Wolf D.H., Corcoran C.M., Horton L.E., Mittal V.A., Schiffman J.E., Ellman L.M., Strauss G.P., Mamah D., Choi J., Pearlson G.D., Shah J.L., Fusar-Poli P., Arango C., Perez J., Koutsouleris N., Wang J., Kwon J.S., Walsh B.C., McGlashan T.H., Hyman S.E., Gur R.E., Cannon T.D., Kane J.M., Anticevic A.  (2021) Counterpoint. Early Intervention for Psychosis Risk Syndromes: Minimizing Risk and Maximizing Benefit. Schizophrenia Research, 2021 Jan; 227:10-17 [Epub 2020 May 10]. PMID:32402605
  8. Corbett S., Farris M.S., MacQueen G., Addington J. (2021) Pilot Aerobic Exercise Intervention for Youth At-risk for Serious Mental Illness. Early Intervention in Psychiatry, 2021 Jun; 15(3):547-553 [Epub 2020 May 26]. PMID:32452641
  9. Farris M.S., Shakeel M.K., MacQueen G., Goldstein B.I., Wang JL., Kennedy S.H., Bray S., Lebel C., Addington J. (2021) Substance Use in Youth At-risk for Serious Mental Illness. Early Intervention in Psychiatry, 2021 Jun; 15(3):634-641 [Epub 2020 Jun 4]. PMID:32500614
  10. LoPilato A.M., Zhang Y., Pike M., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Seidman L., Perkins D.O., Tsuang M.T., Woods S.W., Walker E.F. (2021) Associations between childhood adversity, cognitive schemas and attenuated psychotic symptoms. Early Intervention in Psychiatry, 2021 Aug; 15(4):818-827 [Epub 2020 Aug 7]. PMID:32770658
  11. Calkins M.E., Woods S.W., Bearden C.E., Liu L., Moore T.M., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Mathalon D.H., Keshavan M., Stone W.S., Addington J. (2021) Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis. Schizophrenia Research, 2021 Jan; 227:72-77 [Epub 2020 Sep 14]. PMID:32943313
  12. Addington J., Liu L., Farris M.S., Goldstein B.I., Wang JL., Kennedy S.H., Bray S. Lebel C. MacQueen G. (2021) Clinical staging for youth at‐risk for serious mental illness: A longitudinal perspective. Early Intervention in Psychiatry, 2021 Oct; 15(5):1188-1196 [Epub 2020 Oct 9]. PMID:33037783
  13. Worthington M.A., Walker E.F., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Woods S.W., Cannon T.D. (2021) Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis. Schizophrenia Research, 2021 Jan; 227:95-100 [Epub 2020 Oct 9]. PMID:33046334
  14. Santesteban-Echarri O., Kim G., Haffey P., Tang J., Addington J. (2021) LooseLeaf, a Mobile-Based Application to Monitor Cannabis Use and Cannabis-Related Experiences for Youth at Clinical High-Risk for Psychosis: Development and User Acceptance Testing. International Journal of Human-Computer Interaction, 2021; 37(6):501-511 [Epub 2020 Oct 20].
  15. Addington J., Farris M.S., Liu L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Bearden C.E., Mathalon D.H., Stone W.S., Keshevan M., Woods S.W. (2021) Depression: An actionable outcome for those at clinical high-risk. Schizophrenia Research, 2021 Jan; 227:38-43 [Epub 2020 Oct 28]. PMID:33129638
  16. Carrión R.E., Auther A.M., McLaughlin D., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Keshavan M., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L., Stone W., Tsuang M., Walker E.F., Woods S.W., Torous J., Cornblatt B.A. (2021) Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome. Schizophrenia Research, 2021 Jan; 227:44-51 [Epub 2020 Oct 30]. PMID:33131983
  17. Mittal V.A., Addington J. (2021) Embracing heterogeneity creates new opportunities for understanding and treating those at clinical-high risk for psychosis. Schizophrenia Research, 2021 Jan; 227:1-3 [Epub 2020 Dec 4]. PMID:33288356
  18. Metzak P.D., Addington J., Hassel S., Goldstein B.I., MacIntosh B.J., Lebel C., Wang JL, Kennedy S.H., MacQueen G.M., Bray S. (2021) Functional imaging in youth at risk for transdiagnostic serious mental illness: Initial results from the PROCAN study. Early Intervention in Psychiatry, 2021 Oct; 15(5):1276-1291 [Epub 2020 Dec 8]. PMID:33295151
  19. Addington J., Liu L., Santesteban-Echarri O., Brummitt K., Braun A., Cadenhead K.S., Cornblatt B.A., Holden J., Granholm E. (2021) Cognitive behavioural social skills training: Methods of a randomized controlled trial for youth at risk of psychosis. Early Intervention in Psychiatry, 2021 Dec; 15(6):1626-1636 [Epub 2021 Jan 4]. PMID:33398922
  20. O'Donoghue B., Geros H., Sizer H., Addington J., Amminger G.P., Beaden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Berger G.E., Chen EYH, de Haan L., Hartmann J.A., Hickie I.B., Ising H.K., Lavoie S., Lin A., Markulev C., Mathalon D.H., McGlashan T.H., Mifsud N.G., Mossaheb N., Nieman D.H., Nordentoft M., Perkins D.O., Riecher-Rössler A., Schäfer M.R., Schlögelhofer M., Seidman L.J., Smesny S., Thompson A., Tsuang M.T., van der Gaag M., Verma S., Walker E.F., Wood S.J., Woods S.W., Yuen H.P., Yung A.R., McGorry P.D., Nelson B. (2021) The association between migrant status and transition in an ultra-high risk for psychosis population. Social Psychiatry and Psychiatric Epidemiology, 2021 Jun; 56(6):943-952 [Epub 2021 Jan 5]. PMID:33399885
  21. Addington J., Santesteban-Echarri O., Braun A., Lecomte T. (2021) Assessing Social Functioning in Youth at Clinical High-Risk for Psychosis. Schizophrenia Research, 2021 Jan 11; 228:188-189. PMID:33444935
  22. Farris M.S., Braun A., MacQueen G., Goldstein B.I., Wang JL., Kennedy S.H., Addington J. (2021) Longitudinal Trends in Medication Treatment for Youth At-Risk for Serious Mental Illness. The Canadian Journal of Psychiatry, 2021 Apr; 66(4):418-420 [Epub 2021 Jan 19]. PMID:33464130
  23. Loohuis L.O., Mennigen E., Ori A., Perkins D., Robinson E., Addington J., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Seidman L.J., Keshavan M., Stone W., Tsuang M.T., Walker E.F., Woods S.W., Cannon T.D., Gur R.C., Gur R.E., Bearden C.E., Ophoff R.A. (2021) Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD. Translational Psychiatry, 2021 Jan 28; 11(1):80. PMID:33510130
  24. Foss-Feig J.H., Guillory S.B., Roach B.J., Velthorst E., Hamilton H., Bachman P., Belger A., Carrión R.E., Duncan E., Johannesen J., Light G.A., Niznikiewicz M., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Stone W.S., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H. (2021) Abnormally Large Baseline P300 Amplitude May Predict Conversion to Psychosis in Clinical High Risk Individuals with a History of Autism: A Pilot Study. Frontiers in Psychiatry, 2021 Feb 9; 12:591127. PMID:33633603
  25. Moore D., Castagnini E., Mifsud N., Geros H., Sizer H., Addington J., van der Gaag M., Nelson B., McGorry P., O’Donoghue B. (2021) The Associations between Migrant Status and Ethnicity and the Identification of Individuals at Ultra-High Risk for Psychosis and Transition to Psychosis: A Systematic Review. Social Psychiatry and Psychiatric Epidemiology, 2021 Nov; 56(11):1923-1941 [Epub 2021 Feb 28]. PMID:33641006
  26. Jacob M.S., Roach B.J., Hamilton H.K., Carrión R.E., Belger A., Duncan E., Johannesen J., Keshavan M., Loo S., Niznikiewicz M., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Stone W., Tsuang M., Walker E.F., Woods S.W., Mathalon D.H. (2021) Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study. Schizophrenia Research, 2021 Apr; 230:26-37 [Epub 2021 Mar 2]. PMID:33667856
  27. Lecomte T., Addington J., Bowie C., Lepage M., Potvin S., Shah J., Summerville C., Tibbo P. (In Press) The Canadian Network for Research in Schizophrenia and Psychoses: A Nationally Focused Approach to Psychosis and Schizophrenia Research. The Canadian Journal of Psychiatry, 2021 Apr 19; PMID:33871307
  28. Di Biase M., Karayumak S.C., Lyall A., Zalesky A., Cho K.I.K., Zhang F., Kubicki M., Rathi Y., Lyons M., Bouix S., Billah T., Anticevic A., Schleifer C., Adkinson B., Ji J.L., Tamayo Z., Addington J., Bearden C., Cornblatt B., Keshavan M., Mathalon D., McGlashan T., Perkins D., Cadenhead K., Tsuang M., Woods S.W., Stone W., Shenton M., Cannon T., Pasternak O. (2021) White matter changes in psychosis risk relate to development and are not impacted by the transition to Psychosis. Molecular Psychiatry, 2021 Nov; 26(11):6833-6844 [Epub 2021 May 24]. PMID:34024906
  29. Shakeel M.K., Hassel S., Davis A.D., Metzak P.D., MacQueen G.M., Arnott S.R., Bray S., Frey B.N., Goldstein B.I., Hall G.B., Harris J., Lam R.W., MacIntosh B.J., Milev R., Mueller D.J., Rotzinger S., Strother S.C., Wang JL., Zamyadi M., Kennedy S.H., Addington J., Lebel C. (2021) White Matter Microstructure in Youth at Risk for Serious Mental Illness: A Comparative Analysis. Psychiatry Research: Neuroimaging, 2021 Jun 30; 312:111289. PMID:33910139
  30. Metzak P.D., Farris M.S., Placsko T., Braun A., Bonneville D., Brummitt K., Chu M., Addington J. (2021) Social functioning and brain imaging in individuals at clinical high-risk for psychosis: A systematic review. Schizophrenia Research, 2021 Jun 11; 233:3-12. PMID:34126554
  31. Collins M.A., Chung Y., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Cannon T.D. (2021) Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis. Neuroimage Clinical 2021 Jul 6; 31:102757. PMID:34273790
  32. Santesteban-Echarri O., Liu L., Cadenhead K.S., Tsuang M.T., Cannon T.D., Cornblatt B.A., McGlashan T.H., Woods S.W., Perkins D.O., Seidman L.J., Walker E.F., Bearden C.E., Mathalon D.H., Addington J. (2021) Anxiety in youth at clinical high-risk for psychosis: A two-year follow-up. Schizophrenia Research, 2021 Aug 20; 236:87-88. PMID:34425382
  33. Miklowitz D.J., Addington J., O'Brien M.P., Denenny D.M., Weintraub M.J., Zinberg J.L., Mathalon D.H., Cornblatt B.A., Friedman-Yakoobian M.S., Stone W.S., Cadenhead K.S., Woods S.W., Sugar C.A., Cannon T.D., Bearden C.E. (In Press) Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial. Early Intervention in Psychiatry, 2021 Aug 23; PMID:34427047
  34. Koutsouleris N., Worthington M., Dwyer D.B., Kambeitz-Ilankovic L., Sanfelici R., Fusar-Poli P., Rosen M., Ruhrmann S., Anticevic A., Addington J., Perkins D.O., Bearden C.E., Cornblatt B.A., Cadenhead K.S., Mathalon D.H., McGlashan T.H., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Falkai P., Lencer R., Bertolino A., Kambeitz J., Schultze-Lutter F., Meisenzahl E., Salokangas R.K., Hietala J., Brambilla P., Upthegrove R., Borgwardt S., Wood S., Gur R.E., McGuire P., Cannon T.D. (2021) Towards generalizable and transdiagnostic tools for psychosis prediction:An independent validation and improvement of the NAPLS-2 risk calculator in the multi-site PRONIA cohort. Biological Psychiatry, 2021 Nov 1; 90(9):632-642 [Epub July 2021]. PMID:34482951
  35. Ku B.S., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Compton M.T., Cornblatt B.A., Keshavan M., Mathalon D.H., Perkins D.O., Stone W.S., Tsuang M.T., Walker E.F., Woods S.W., Druss B.G. (2021) Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophrenia Research, 2021 Dec; 238:137-144 [Epub 2021 Oct 19]. PMID:34673386
  36. Devoe D., Cadenhead K.S., Cornblatt B.A., Granholm E., Addington J. (In Press) Negative symptoms: associations with defeatist beliefs, self-efficacy, and maladaptive schemas in youth and young adults at-risk for psychosis. Behavioural and Cognitive Psychotherapy, 2021 Nov 17; 1-14. PMID:34784991
  37. Tempelaar W., Barwick M., Crawford A., Voineskos A., Addington D., Addington J., Alexander T., Baluyut C., Bromley S., Durbin J., Foussias G., Ford C., de Freitas L., Jindani S., Kirvan A., Kurdyak P., Pauly K., Polillo A., Roby R., Sockalingam S., Sosnowski A., Villanueva V., Wang W., Kozloff N. (2021) Adapting evidence-based early psychosis intervention services for virtual delivery: Protocol for a pragmatic mixed-methods implementation and evaluation study. JMIR Research Protocols 2021 Dec 7; 10(12):e34591. PMID:34806990
  38. Kelsven S., Brummitt K., Devoe D., Santesteban-Echarri O., Auther A., Cornblatt B., Cadenhead K., Granholm E., Holden J., Kelly M., Addington J. (In Press) Cognitive-Behavioral Social Skills Training Adapted for Youth at Clinical High Risk for Psychosis. Journal of Cognitive Psychotherapy, 2021 Dec;
  39. Deng W., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Woods S.W., Walker E.F., Joormann J., Cannon T.D. (In Press) Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis. Psych Res Clin Pract., 2021 Dec;

2020

  1. Santesteban-Echarri O., Piskulic D., Nyman R., Addington J. (2020) Telehealth Interventions for Schizophrenia-Spectrum Disorders and Clinical High-Risk for Psychosis Individuals: A Scoping Review. Journal of Telemedicine and Telecare, 2020 Jan-Feb; 26 (1-2):14-20 [Epub 2018 Aug 22].  PMID:30134781
  2. Cao H., Chung Y., McEwen S.C., Bearden C.E., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Carrión R., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H., Tsuang M.T., van Erp T.G.M., Walker E.F., Hamann S., Anticevic A., Woods S.W., Cannon T.D. (2020) Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophrenia Research, 2020 Dec; 226:30-37 [Epub 2019 Jan 28]. PMID:30704864
  3. LoPilato A.M., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Tsuang M.T., Woods S.W., Walker E.F. (2020) Stress perception following childhood adversity: Unique associations with adversity type and sex. Development and Psychopathology, 2020 Feb; 32(1): 343-356 [Epub 2019 Mar 8]. PMID:30846020
  4. Shakeel M. K., Lu L., Woods S.W., Perkins D.O., Addington J. (2020) Neurocognitive predictors of metacognition in individuals at clinical high risk for psychosis. Behavioral and Cognitive Psychotherapy, 2020 Mar; 48(2): 248-252 [Epub 2019 Apr 15]. PMID:30982487
  5. Farris M.S., Devoe D.J., Addington J. (2020) Attrition rates in trials for adolescents and young adults at clinical high-risk for psychosis: A systematic review and meta-analysis. Early Intervention in Psychiatry, 2020 Oct; 14(5):515-527 [Epub 2019 Aug 18]. PMID:31422583
  6. Romanowska S., MacQueen G., Goldstein B.I., Wang JL., Kennedy S.H., Bray S., Lebel C., Addington J. (2020) Social and role functioning in youth at risk of serious mental illness. Early Intervention in Psychiatry, 2020 Aug; 14(4):463-469 [Epub 2019 Sep 10]. PMID:31502422
  7. Allswede D.M., Addington J., Bearden C.E., Cadenhead K., Cornblatt B., Mathalon D.H., McGlashan T., Perkins D., Seidman L.J., Tsuang M., Walker E., Woods S.W., Cannon T.D. (2020) Characterizing covariant trajectories of individuals at clinical high-risk for psychosis across symptomatic and functional domains. American Journal of Psychiatry, 2020 Feb 1; 177(2):164-171 [Epub 2019 Sep 6]. PMID:31509005
  8. Nogovitsyn N., Muller M., Souza R., Hassel S., Arnott S., Davis A., Hall G., Harris J., Zamyadi M., Metzak P., Ismail Z., Downar J., Parikh S., Soares C., Addington J., Milev R., Harkness K., Frey B., Lam R., Strother S., Rotzinger S., Kennedy S., MacQueen G. (2020) Hippocampal Tail Volume as a Predictive Biomarker of Antidepressant Treatment Outcomes in Patients With Major Depressive Disorder: A CAN-BIND Report. Neuropsychopharmacology, 2020 Jan; 45 (2), 283-291 [Epub 2019 Oct 14]. PMID:31610545
  9. Perkins D.O., Loohuis L.O., Barbee J., Ford J., Jeffries C.D., Addington J., Bearden C., Cadenhead K., Cannon T., Cornblatt B., Mathalon D., McGlashan T., Seidman L., Tsuang M., Walker E.F., Woods S.W. (2020) Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High-Risk. American Journal of Psychiatry, 2020 Feb 1; 177(2):155-163 [Epub 2019 Nov 12]. PMID:31711302
  10. Stowkowy J., Goldstein B.I., MacQueen G., Wang JL., Kennedy S.H., Bray S., Lebel C., Addington J. (2020) Trauma in Youth At-Risk for Serious Mental Illness. Journal of Nervous and Mental Disease, 2020 Jan; 208 (1), 70-76. PMID:31834192
  11. Stowkowy J., Brummitt K., Bonneville D., Goldstein B.I., Wang JL., Kennedy S.H., Bray S., Lebel C., MacQueen G., Addington J. (2020) Sleep Disturbances in Youth At-Risk for Serious Mental Illness. Early Intervention in Psychiatry, 2020 Jun; 14(3):373-378 [Epub 2019 Nov 13]. PMID:31724327
  12. Farris M.S., Shakeel M.K.Addington J. (2020) Cannabis use in individuals at clinical high-risk for psychosis: A comprehensive review. Social Psychiatry and Psychiatric Epidemiology, 2020 May; 55(5):527-537 [Epub 2019 Dec 3]. PMID:31796983
  13. Powers A., Addington J., Perkins D., Bearden C., Cadenhead K., Cannon T., Cornblatt B., Mathalon D., Seidman L., Tsuang M., Walker E., McGlashan T., Woods S. (2020) Duration of the Psychosis Prodrome. Schizophrenia Research, 2020 Feb; 216:443-449 [Epub 2019 Dec 2]. PMID:31806523
  14. Yoviene Sykes L.A., Ferrara M., Addington J., Bearden C., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Perkins D.O., Mathalon D.H., Seidman L.J., Tsuang M.T., Walker E.F., McGlashan T.H., Woodberry K., Powers III A., Ponce A.N., Cahill J., Pollard J.M., Srihari V., Woods S.W. (2020) Predictive Validity of Conversion from the Clinical High Risk Syndrome to Frank Psychosis. Schizophrenia Research, 2020 Feb; 216:184-191 [Epub 2019 Dec 19]. PMID:31864837
  15. Nogovitsyn N., Souza R., Muller M., Srajer A., Metzak P., Hassel S., Ismail Z., Protzner A., Bray S.L., Lebel C., MacIntosh B.J., Goldstein B.I, Wang JL., Kennedy S.H., Addington J., MacQueen G.M. (2020) Aberrant limbic brain structures in young individuals at risk for mental illness. Psychiatry and Clinical Neurosciences, 2020 May; 74(5):294-302 [Epub 2020 Feb 27]. PMID:32003517
  16. Cullen A.E., Addington J., Bearden C.E., Stone W.S., Seidman L.J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Tsuang M.T., Woods S.W., Walker E.F. (2020) Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort. Psychoneuroendocrinology, 2020 May; 115, 104649 [Epub 2020 Mar 7]. PMID:32197198
  17. Roach B.J., Hamilton H.K., Bachman P., Belger A., Carrión R.E. , Duncan E., Johannesen J., Kenney J.G., Light G. , Niznikiewicz M., Addington J., Bearden C.E., Owens E.M., Cadenhead K.S., Cannon T.D. , Cornblatt B.A. , McGlashan T.H., Perkins D.O., Seidman L., Tsuang M., Walker E.F., Woods S.W., Mathalon D.H. . (2020) Stability of Mismatch Negativity Event-Related Potentials in a Multisite Study. International Journal of Methods in Psychiatric Research, 2020 Jun; 29(2):e1819 [Epub 2020 Mar 30]. PMID:32232944
  18. Santesteban-Echarri O., Tang J., Shakeel M.K., Fernandes J., Addington J. (2020) A Mobile-Based App to Monitor Social Functioning Among Youth At-Risk for Psychosis: Single-arm Feasibility and Acceptability Study. General Hospital Psychiatry, 2020 Nov-Dec; 67:148-149 [Epub 2020 Apr 10]. PMID:32317101
  19. Addington J., Liu L., Brummitt K., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Keshavan M., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Stone W., Tsuang M.T., Walker E.F., Woods S.W., Cannon T.D. (In Press) North American Prodrome Longitudinal Study (NAPLS 3): Methods and Baseline Description. Schizophrenia Research, 2020 Apr 18; PMID:32317224
  20. Santesteban-Echarri O., Tang J., Fernandes J., Addington J. (2020) Development and Usability Testing of SOMO, a Mobile-Based Application to Monitor Social Functioning for Youth at Clinical High-Risk for Psychosis. Digital Psychology, 2020 June; 1(1):4-19
  21. Devoe D.J., Farris M.S., Townes P., Addington J. (2020) Interventions and Transition in Youth at Risk of Psychosis: A Systematic Review and Meta-Analyses. The Journal of Clinical Psychiatry, 2020 May 19; 81(3):17r12053. PMID:32433834
  22. Kozloff N., Foussias G., Durbin J., Sockalingam S., Addington J., Addington D., Ampofo A., Anderson K.K., Barwick M., Bromley S., Cunningham J., Dahrouge S., Duda L., Ford C., Gallagher S., Haltigan J.D., Henderson J., Jaouich A., Miranda D., Mitchell P., Morin J., de Oliveira C., Primeau V., Serhal E., Soklaridis S., Urajnik D., Whittard K., Zaheer J., Kurdyak P., Voineskos A.N. (2020) Early Psychosis Intervention-Spreading Evidence-based Treatment (EPI-SET): protocol for an effectiveness-implementation study of a structured model of care for psychosis in youth and emerging adults. BMJ Open, 2020 Jun 3; 10(6):e034280. PMID:32499262
  23. Shakeel M.K., MacQueen G., Addington J., Metzak P.D., Georgopoulos G., Bray S., Goldstein B.I., MacIntosh B.J., Wang JL., Kennedy S.H., Lebel C. (2020) White Matter Connectivity in Youth at Risk for Serious Mental Illness: A Longitudinal Analysis. Psychiatry Research: Neuroimaging, 2020 Aug; 302:111106 [Epub 2020 May 22]. PMID:32505905
  24. Santesteban-Echarri O., Haffey P., Kim GH., Tang J., Addington J. (2020) A Mobile-Based App to monitor cannabis use among Youth at Clinical High Risk (CHR) for Psychosis: Feasibility and Acceptability of LooseLeaf. Schizophrenia Research, 2020 Aug; 222:505-506. PMID:32522468
  25. Fryer S.L., Roach B.J., Hamilton H.K., Bachman P., Belger A., Carrión R.E., Duncan E., Johannesen J., Light G.A., Niznikiewicz M., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L., Tsuang M., Walker E.F., Woods S.W., Mathalon D.H. (2020) Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis.  Journal of Abnormal Psychology, 2020 Aug; 129(6):599-611. PMID:32757603
  26. Metzak P.D., Devoe D.J., Iwaschuk A., Braun A., Addington J. (2020) Brain changes associated with negative symptoms in clinical high risk for psychosis: A systematic review. Neuroscience and Biobehavioral Reviews, 2020 Nov; 118:367-383 [Epub 2020 Aug 6]. PMID:32768487
  27. Nogovitsyn N., Addington J., Souza R., Placsko T.J., Stowkowy J., Wang JL., Goldstein B.I., Bray S., Lebel C., Taylor V.H., Kennedy S.H., MacQueen G. (In Press) Childhood Trauma and Amygdala Nuclei Volumes in Youth at Risk for Mental Illness. Psychological Medicine, 2020 Sep 17; 1-8. PMID:32940197
  28. Cadenhead K.S., Duncan E., Addington J., Bearden C.E., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L., Tsuang M., Walker E.F., Woods S.W., Bauchman P., Belger A., Carrión R.E., Donkers F., Johannesen J., Light G., Niznikiewicz M., Nunag J., Roach B.J. on behalf of the North American Prodromal Longitudinal Studies Consortium (2020) Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis from the NAPLS Consortium Assessed with the Human Startle Paradigm. Frontiers in Psychiatry, 2020 Aug 25; 11:833. PMID:33005152
  29. Addington J., Farris M.S., Devoe D.J., Metzak P. (2020) Progression from Being At-Risk to Psychosis: Next Steps. npj Schizophrenia, 2020 Oct 5; 6(1):27. PMID:33020486
  30. Corbett S., Metzak P., MacQueen G., Farris M., Addington J. (2020) Aerobic Exercise and Hippocampal Change in Youth at Risk of Serious Mental Illness. Psychiatry Research: Neuroimaging, 2020 Oct 3; 305:111199. PMID:33035755
  31. Devoe D., Braun A., Seredynski T., Addington J. (2020) Negative Symptoms and Functioning in Youth at Risk of Psychosis: A Systematic Review and Meta-Analysis. Harvard Review of Psychiatry, 2020 Nov; 28(6):341-355. PMID:33156155
  32. Roach B.J., Carrión R.E., Hamilton H.K., Bachman P., Belger A., Duncan E., Johannesen J., Light G.A., Niznikiewicz M., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L., Tsuang M., Walker E.F., Woods S.W., Mathalon D.H. (2020) Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects study. Clinical Neurophysiology, 2020 Oct 22; 131(12):2899-2909. PMID:33160266

2019

  1. Marshall C., Lu Y., Lyngberg K., Deighton S., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D., Addington J. (2019) Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Intervention in Psychiatry, 2019 Apr; 13(2):257-263 [Epub 2017 Aug 3]. PMID:28771938
  2. Georgopoulos G., Stowkowy J., Liu L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H., Addington J. (2019) The Role of a family history of psychosis for youth at clinical high risk of psychosis. Early Intervention in Psychiatry, 2019 Apr; 13(2):251-256 [Epub 2017 Aug 9]. PMID:28792113
  3. Cao H., McEwen S.C., Forsyth J.K., Gee D.G., Bearden C.E., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Carrión R.E., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H., Tsuang M.T., van Erp T.G.M., Walker E.F., Hamann S., Anticevic A., Woods S.W., Cannon T.D. (2019) Toward leveraging human connectomic data in large consortia: Generalizability of  fMRI-based brain graphs across sites, sessions, and paradigms. Cerebral Cortex, 2019 Mar 1; 29(3):1263-1279 [Epub 2018 Mar 7]. PMID:29522112
  4. Devoe D.J., Farris M.S., Townes P., Addington J. (2019) Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta-analysis. Early Intervention in Psychiatry, 2019 Feb; 13(1):3-17 [Epub 2018 May 11]. PMID:29749710
  5. Devoe D.J., Farris M.S., Townes P., Addington J. (2019) Interventions and Social Functioning in Youth at Risk of Psychosis: A Systematic Review and Meta-Analysis. Early Intervention in Psychiatry, 2019 Apr; 13(2):169-180 [Epub 2018 June 25]. PMID:29938910
  6. Farris M.S., MacQueen G., Goldstein B.I., Wang J., Kennedy S.H., Bray S., Lebel C., Addington J. (2019) Treatment History of Youth At-Risk for Serious Mental Illness. Canadian Journal of Psychiatry, 2019 Feb; 64(2):145-154 [Epub 2018 Aug 2]. PMID:30071747
  7. Velthorst E., Meyer E.C., Giuliano A.J., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O.,Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Seidman L.J. (2019) Neurocognitive Profiles in the Prodrome to Psychosis in NAPLS-1. Schizophrenia Research, 2019 Feb; 204:311-319 [Epub 2018 Aug 2]. PMID:30078717
  8. Mueser K.T., Meyer P.S., Glynn S.M., Lynde D.W., Robinson D.G., Gingerich S., Penn D.L., Cather C., Gottlieb J.D., Marcy P., Wiseman J.L., Potretzke S., Brunette M.F., Schooler N.R., Addington J., Rosenheck R.A., Estroff S.E., Kane J.M. (2019) Implementation and Fidelity Assessment of the NAVIGATE Treatment Program for First Episode Psychosis in a Multi-site Study. Schizophrenia Research, 2019 Feb; 204:271-281 [Epub 2018 Aug 20]. PMID:30139553
  9. Addington J., Stowkowy J., Liu L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Bearden C.E., Mathalon D.H., Santesteban-Echarri O., Woods S.W. (2019) Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychological Medicine, 2019 Jul; 49(10):1670-1677 [Epub 2018 Sep 4]. PMID:30176955
  10. Shakeel M.K., Lu L., Cannon T.D., Cadenhead K.S., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Woods S.W., Walker E.F., Mathalon D.H., Bearden C.E., Addington J. (2019) Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis. Schizophrenia Research, 2019 Feb; 204:334-336 [Epub 2018 Sep 1]. PMID:30181061
  11. Cao H., McEwen S.C., Chung Y., Chén O.Y., Bearden C.E., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Carrión R.E., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H., Tsuang M.T., van Erp T.G.M., Walker E.F., Hamann S., Anticevic A., Woods S.W., Cannon T.D. (2019) Altered brain activation during memory retrieval precedes and predicts conversion to psychosis in individuals at clinical high risk. Schizophrenia Bulletin, 2019 Jun 18; 45(4):924-933 [Epub 2018 Sep 11]. PMID:30215784
  12. Cadenhead K.S., Minichino A., Kelsven S., Addington J., Bearden C., Cannon T.D., Cornblatt B.A., Mathalon D., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Yao J. the North American Prodromal Longitudinal Studies (NAPLS) consortium (2019) Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium. Schizophrenia Research, 2019 Feb; 204:96-103 [Epub 2018 Sep 22]. PMID:30249470
  13. Carrión R.E., Auther A.M., McLaughlin D., Olsen R., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Cornblatt B.A. (2019) The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis. Schizophrenia Bulletin, 2019 Jun 18; 45(4):763-772 [Epub 2018 Oct 22]. PMID:30351423
  14. Ward H.B., Lawson M.T., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Jeffries C.D., Mathalon D.H., McGlashan T.H., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Perkins D.O. (2019) Tobacco use and psychosis risk in persons at clinical high risk. Early Intervention in Psychiatry, 2019 Oct; 15(5):1173-1181 [Epub 2018 Oct 25]. PMID:30362261
  15. Goldsmith D.R., Haroon E., Miller A.H., Addington J., Bearden C., Cadenhead K., Cannon T., Cornblatt B., Mathalon D., McGlashan T., Seidman L., Tsuang M., Woods S.W., Walker E.F., Perkins D.O. (2019) Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain, Behavior, and Immunity, 2019 Feb; 76:268-274 [Epub 2018 Nov 26]. PMID:30496778
  16. Addington J., Liu L., Goldstein B.I., Wang JL., Kennedy S.H., Bray S., Lebel C., Stowkowy J., MacQueen G. (2019)  Clinical staging for youth at-risk for serious mental illness. Early Intervention in Psychiatry, 2019 Dec; 13 (6), 1416-1423 [Epub 2019 Jan 22]. PMID:30672153
  17. Chung Y., Addington J., Bearden C.E., Cadenhead K., Cornblatt B., Mathalon D.H., McGlashan T., Perkins D., Seidman L.J., Tsuang M., Walker E., Woods S.W., McEwen S., van Erp T.G.M., Cannon T.D. North American Prodrome Longitudinal Study Consortium (2019)  Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study. Schizophrenia Research, 2019 Jun; 208:41-43 [Epub 2019 Feb 7]. PMID:30745066
  18. LoPilato A.M., Goines K., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Seidman L., Perkins D.O., Tsuang M.T., Woods S.W., Walker E.F. (2019)  Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis. Schizophrenia Research, 2019 Nov; 213:48-55 [Epub 2019 Feb 7]. PMID:30745068
  19. Brodey B.B., Girgis R.R., Favorov O.V., Bearden C.E., Woods S.W., Addington J., Perkins D.O., Walker E.F., Cornblatt B.A., Brucato G., Purcell S.E., Elkin K.A., Brodey I.S., Cadenhead K.S. (2019) The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning. Schizophrenia Research, 2019 Jun; 208:390-396 [2019 Feb 15]. PMID:30777603
  20. Foss-Feig J.H., & Velthorst E., Smith L., Reichenberg A., Addington J., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Diana O. Perkins D.O., Seidman L.J., Stone W.S., Keshavan M., Tsuang M.T., Walker E.F., Woods S.W., Cannon T.D., Bearden C.E. (2019) Clinical profiles and conversion rates among young individuals with autism spectrum disorder who present to clinical high risk for psychosis services. Journal of the American Academy of Child and Adolescent Psychiatry, 2019 Jun; 58(6):582-588 [Epub 2019 Feb 20]. PMID:30797038
  21. MacQueen G.M., Hassel S., Arnott S.R. Addington J., Bowie C.R., Bray S.L., Davis A.D., Downar J., Foster J.A., Frey B.N., Goldstein B.I., Hall G.B., Harkness K.L., Harris J., Lam R.W., Lebel C., Milev R., Müller D.J., Parikh S.V., Rizvi S., Rotzinger S., Sharma G.B., Soares C.N., Turecki G., Vila-Rodriguez F., Yu J., Zamyadi M., Strother S.C., Kennedy S.H. on behalf of the CAN-BIND Investigator Team (2019) The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols. Journal of Psychiatry and Neuroscience, 2019 Mar 6; 44(3):1-14. PMID:30840428
  22. Addington J., Farris M., Stowkowy J., Santesteban-Echarri O., Metzak P., Kalathil M.S. (2019) Predictors of Transition to Psychosis in Individuals at Clinical High Risk. Current Psychiatry Reports, 2019 June; 21(6):39 [Epub 2019 April 29]. PMID:31037392
  23. Nogovitsyn N., Souza R., Muller M., Srajer A., Hassel S., Arnott S.R., Davis A.D., Hall G.B., Harris J.K., Zamyadi M., Metzak P.D., Ismail Z., Bray S.L., Lebel C., Addington J., Milev R., Harkness K.L., Frey B.N., Lam R.W., Strother S.C., Goldstein B.I., Rotzinger S., Kennedy S.H., MacQueen G.M. (2019) Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants. Neuroimage, 2019 Aug 15; 197:589-597 [Epub 2019 May 7]. PMID:31075395
  24. Chung Y., Allswede D., Addington J., Bearden C.E., Cadenhead K., Cornblatt B., Mathalon D.H., McGlashan T., Perkins D., Seidman L.J., Tsuang M., Walker E., Woods S.W., McEwen S., van Erp T.G.M., Cannon T.D.; North American Prodrome Longitudinal Study (NAPLS) Consortium. (2019) Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort. Neuroimage Clinical, 2019 May 23; 23:101862. PMID:31150956
  25. Malda A., Boonstra N., Barf H., de Jong S., Aleman A., Addington J., Pruessner M., Nieman D., De Haan L., Morrison A., Riechler-Rössler A., Studerus E., Ruhrmann S., Schultze-Lutter F., An S.K., Koike S., Kasai K., Nelson B., McGorry P., Wood S., Lin A., Yung A.Y., Kotlicka-Antczak M., Armando M., Vicari S., Katsura M., Matsumoto K., Durston S., Ziermans T., Wunderink L., Ising H., van Der Gaag M., Fusar-Poli P., Pijnenborg G.H.M. (2019) Individualized prediction of transition to psychosis in 1676 individuals at Clinical High Risk: Development and validation of a multivariable prediction model based on Individual Patient Data Meta-analysis. Frontiers in Psychiatry, 2019 May 21; 10:345. PMID:31178767
  26. Addington J., Shakeel M.K., Braun A., Bonneville D., Stowkowy J. (2019) Metacognition in Youth At-Risk for Psychosis. Schizophrenia Research, 2019 Aug; 210:303-305 [Epub 2019 July 9].  PMID:31296413
  27. Goines K.B., LoPilato A.M., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Tsuang M.T., Woods S.W., Walker E.F. (2019) Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis. Psychiatry Research, 2019 Dec; 282:112492 [Epub 2019 Aug 3]. PMID:31387769
  28. Hamilton H.K., Roach B.J., Bachman P.M., Belger A., Carrión R.E., Duncan E., Johannesen J.K., Light G.A., Niznikiewicz M.A., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Cannon T.D., Mathalon D.H. (2019) Association between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. JAMA Psychiatry, 2019 Aug 7; 76(11):1187-1197. PMID:31389974
  29. Addington J., Devoe D., Santesteban-Echarri O. (2019) Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis. Current Treatment Options in Psychiatry, 2019 Mar; 6 (1), 1-16 [Epub 2019 Jan 31]. PMID:31403023

2018

  1. McAusland L. & Addington J. (2018) Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis. Early Intervention in Psychiatry, 2018 Aug; 12(4):694-701 [Epub 2016 Aug 29]. PMID:27573093
  2. Woodberry K., Bearden C.E., Woods S.W., Bryant C., Addington J., Cadenhead K.S., Cornblatt B.A.,Cannon T.D., Mathalon D., Perkins D.O., Tsuang M.T., Walker E.F., Seidman L.J., McGlashan T.H. (2018) Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort. Journal of Clinical Child and Adolescent Psychology, 2018 Jan-Feb; 47(1):69-78 [Epub 2016 Oct 5]. PMID:27705009
  3. Velthorst E., Zinberg J., Addington J., Cadenhead K.S., Cannon T.D., Carrión R.E., Auther A., Cornblatt B.A., McGlashan T.H., Mathalon D.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Reichenberg A., Bearden C.E. (2018) Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis. Development and Psychopathology, 2018 Feb; 30(1):39-47 [Epub 2017 Apr 19]. PMID:28420458
  4. Kline E.R., Seidman L.J., Cornblatt B.A., Woodberry K.A., Bryant C., Bearden C.E., Cadenhead K.S., Cannon T.D., Mathalon D.H., McGlashan T.H., Perkins D.O., Tsuang M.T., Walker E.F., Woods S.W., Addington J. (2018) Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort . Schizophrenia Research, 2018 Feb; 192:357-363 [Epub 2017 June 1]. PMID:28578922
  5. Fulford D., Piskulic D., Addington J., Kane J.M., Schooler N.R., Mueser K.T. (2018) Prospective Relationships Between Motivation and Functioning in Recovery After a First Episode of Schizophrenia. Schizophrenia Bulletin, 2018 Feb 15; 44(2):369-377 [Epub 2017 Aug 18]. PMID:28981811
  6. Woods S.W., Powers A.R. 3rd,Taylor J.H., Davidson C.A., Johannesen J.K., Addington J., Perkins D.O., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Seidman L.J., Tsuang M.T., Walker E.F., McGlashan T.H. (2018) Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups. Schizophrenia Bulletin, 2018 Feb 15; 44(2):254-263 [Epub 2017 Sep 28]. PMID:29036402
  7. Healey K.M., Penn D.L., Perkins D., Woods S.W., Keefe R.S.E., Addington J. (2018) Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction. Schizophrenia Bulletin, 2018 Feb 15; 44(2):286-296 [Epub 2017 July 14]. PMID:29036587
  8. Nagendra A., Schooler N.R., Kane J.M., Robinson D.G., Mueser K.T., Estroff S.E., Addington J., Marcy P., Penn D.L. (2018) Demographic, psychosocial, clinical, and neurocognitive baseline characteristics of Black Americans in the RAISE-ETP study. Schizophrenia Research, 2018 Mar; 193:64-68 [Epub 2017 July 11]. PMID:28709773
  9. Brunette M.F., Mueser K.T., Babbin S., Meyer-Kalos P., Rosenheck R., Correll C.U., Cather C., Robinson D.G., Schooler N.R., Penn D.L., Addington J., Estroff S.E., Gottlieb J., Glynn S.M., Marcy P., Robinson J., Kane J.M. (2018) Demographic and clinical correlates of substance use disorders in first episode psychosis. Schizophrenia Research, 2018 Apr; 194:4-12 [Epub 2017 July 8]. PMID:28697856
  10. Tarbox-Berry S.I., Perkins D.O., Woods S.W., Addington J. (2018) Premorbid social adjustment and association with attenuated psychotic symptoms in clinical high-risk and help-seeking youth. Psychological Medicine, 2018 Apr; 48(6):983-997 [Epub 2017 Sep 6]. PMID:28874223
  11. Stowkowy J., Liu L., Cadenhead K.S., Tsuang M.T., Cannon T.D., Cornblatt B.A., McGlashan T.H., Woods S.W., Perkins D.O., Seidman L.J., Walker E.F., Bearden C.E., Mathalon D.H., Addington J. (2018) Exploration of clinical high-risk dropouts: Letter to the Editor. Schizophrenia Research, 2018 May; 195:579-580 [Epub 2017 Sep 28]. PMID:28964651
  12. Devoe D.J., Peterson A., Addington J. (2018) Negative Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Network Meta-Analysis. Schizophrenia Bulletin, 2018 Jun 6; 44(4):807-823 [Epub 2017 Oct 24]. PMID:29069511
  13. Piskulic D., Romanowska S., Addington J. (2018) Pilot study of cognitive remediation and motivational interviewing in youth at risk of serious mental illness. Early Intervention in Psychiatry, 2018 Dec; 12(6):1193-1197 [Epub 2017 Nov 22]. PMID:29164824
  14. Brodey B.B., Addington J., First M.B., Perkins D.O., Woods S.W., Walker E.F., Walsh B.., Nieri J.M., Nunn M.B., Putz J., Brodey I.S. (2018) The Early Psychosis Screener (EPS): Item development and qualitative validation. Schizophrenia Research, 2018 July; 197:504-508 [Epub 2017 Dec 15]. PMID:29254878
  15. Ryan A.T., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Woods S.W., Cannon T.D., Walker E.F. (2018) Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome. Schizophrenia Research, July 2018; 197:522-530 [Epub 2017 Dec 23]. PMID:29279247
  16. Brodey B.B., Girgis R.R., Favorov O.V., Addington J., Perkins D.O., Bearden C.E., Woods S.W., Walker E.F., Cornblatt B.A., Brucato G., Walsh B., Elkin K.A., Brodey I.S. (2018) The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning. Schizophrenia Research, July 2018; 197:516-521 [Epub 2018 Jan 18]. PMID:29358019
  17. Davidson C.A., Piskulic D., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Bearden C.E., Mathalon D.H., Woods S.W., Johannesen J.K. (2018) Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study. Schizophrenia Research, 2018 Nov; 201:130-136 [Epub 2018 May 8]. PMID:29751984
  18. Correll C.U., Galling B., Pawar A., Krivko A., Bonetto C., Ruggeri M., Craig T.J., Nordentoft M., Srihari V.H., Guloksuz S., Hui C.L.M., Chen E.Y.H., Valencia M., Juarez F., Robinson D.G., Schooler N.R., Brunette M.F., Mueser K.T., Rosenheck R.A., Marcy P., Addington J., Estroff S.E., Robinson J., Penn D., Severe J.B., Kane J.M. (2018) Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression. JAMA Psychiatry, 2018 Jun 1; 75(6):555-565 [Epub 2018 May 2]. PMID:29800949
  19. Jeffries C.D., Perkins D.O., Fournier M., Do K.Q., Cuenod M., Khadimallah I., Domenici E., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Seidman L.J., Tsuang M., Walker E.F., Woods S.W. (2018) Networks of blood proteins in the neuroimmunology of schizophrenia. Translational Psychiatry, 2018 Jun 6; 8(1):112. PMID:29875399
  20. Hampton J.N., Trotman H.D., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Tsuang M.T., Perkins D.O., Seidman L.J., Woods S.W., Walker E.F. (2018) The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis. Stress and Health, 2018 Dec; 34(5):591-600 [Epub 2018 June 28]. PMID:29956456
  21. Chung Y., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., McEwen S., van Erp T., Cannon T.D., for the North American Prodrome Longitudinal Study (NAPLS) Consortium and the Pediatric Imaging, Neurocognition, and Genetics (PING) Study Consortium (2018) Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated with Future Psychosis in Youths at Clinically High Risk. JAMA Psychiatry, 2018 Sep 1; 75(9):960-968 [Epub 2018 July 3]. PMID:29971330
  22. Addington J., Goldstein B.I., Wang JL., Kennedy S.H., Bray S., Lebel C., Hassel S., Marshall C., MacQueen G. (2018) Youth at-risk for serious mental illness: methods of the PROCAN study. BMC Psychiatry, 2018 Jul 5; 18(1):219. PMID:29976184
  23. Santesteban-Echarri O., MacQueen G., Goldstein B.I., Wang JL., Kennedy S.H., Bray S., Lebel C., Addington J. (2018) Family Functioning in Youth At-Risk for Serious Mental Illness. Comprehensive Psychiatry, 2018 Aug 25; 87:17-24. PMID:30193153
  24. Cao H., Chen O.Y., Chung Y., Forsyth J.K., McEwen S.C., Gee D.G., Bearden C.E., Addington J., Goodyear B., Kristin S. Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Carrión R.E., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H., Tsuang M.T., van Erp T.G.M., Walker E.F., Hamann S., Anticevic A., Woods S.W., Cannon T.D. (2018) Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization. Nature Communications, 2018 Sep 21; 9(1):3836. PMID:30242220
  25. Birnbaum M.L., Rizvi A.F., Faber K., Addington J., Correll C.U., Gerber C., Lahti A.C., Loewy R.L., Mathalon D.H., Nelson LA., Voineskos A.N., Walker E.F., Ward E., Kane J.M. (2018) Digital trajectories to care in first episode psychosis. Psychiatric Services, 2018 Dec 1; 69(12):1259-1263 [Epub 2018 Sep 26]. PMID:30256181
  26. Romanowska S., MacQueen G., Goldstein B.I., Wang JL., Kennedy S.H., Bray S., Lebel C., Addington J. (2018) Neurocognitive Deficits in a Transdiagnostic Clinical Staging Model. Psychiatry Research, 2018 Dec; 270:1137-1142 [Epub 2018 Oct 17]. PMID:30360915

2017

  1. Kuang C., Buchy L., Barbato M., Makowski C., MacMaster F.P., Bray S., Deighton S., Addington J. (2017) A pilot study of cognitive insight and structural covariance in first-episode psychosis. Schizophrenia Research, 2017 Jan 1; 179:91-96 [Epub 2016 Oct 6]. PMID:27720314   https://www.ncbi.nlm.nih.gov/pubmed/?term=27720314
  2. Addington J., Liu L., Perkins D.0., Carrión R., Keefe R.S.E., Woods S.W. (2017) The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth with Attenuated Psychotic Symptoms. Schizophrenia Bulletin, 2017 Jan 1; 43(1)57-63 [Epub 2016 Oct 25]. PMID:27798225   https://www.ncbi.nlm.nih.gov/pubmed/?term=27798225
  3. Noble S., Scheinost D., Finn E.S., Shen X., Papademetris X., McEwen S.C., Bearden C.E., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Olvet D.M., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H., Tsuang M.T., van Erp T.G., Walker E.F., Hamann S., Woods S.W., Cannon T.D., Constable T. (2017) Multisite Reliability of MR-Based Functional Connectivity. Neuroimage, 2017 Feb 1; 146:959-970 [Epub 2016 Oct 13]. PMID:27746386   https://www.ncbi.nlm.nih.gov/pubmed/?term=27746386
  4. Mueser K.T., Kim M., Addington J., McGurk S.R., Pratt S.I., Addington D.E. (2017) Confirmatory Factor Analysis of the Quality of Life Scale and New Proposed Factor Structure for the Quality of Life Scale-Revised. Schizophrenia Research, 2017 Mar; 181:117-123 [Epub 2016 Oct 15]. PMID:27756514   https://www.ncbi.nlm.nih.gov/pubmed/?term=27756514
  5. Browne J., Penn D.L., Meyer-Kalos P.S., Mueser K.T., Estroff S.E., Brunette M.F., Correll C.U., Robinson J., Rosenheck R.A., Schooler N., Robinson D.G., Addington J., Marcy P., Kane J. (2017) Psychological Well-Being and Mental Health Recovery in the NIMH RAISE Early Treatment Program. Schizophrenia Research, 2017 Jul; 185:167-17 [Epub 2016 Nov 29]. PMID:27913160   https://www.ncbi.nlm.nih.gov/pubmed/?term=27913160
  6. Browne J., Penn D.L., Bauer D.J., Meyer-Kalos P., Mueser K.T., Robinson D.G., Addington J., Schooler N.R., Glynn S.M., Gingerich S., Marcy P., Kane J.M. (2017) Perceived Autonomy Support in the NIMH RAISE Early Treatment Program. Psychiatric Services, 2017 Sep 1; 68(9):916-922 [Epub 2017 Jun 1]. PMID:28566027   https://www.ncbi.nlm.nih.gov/pubmed/?term=28566027
  7. Addington J., Addington D., Abidi S., Raedler T., Remington G. (2017) CPA Treatment Guidelines for Individuals at Clinical High Risk of Psychosis. Canadian Journal of Psychiatry, 2017 Sep; 62(9):656-661 [Epub 2017 Jul 21]. PMID:28730848   https://www.ncbi.nlm.nih.gov/pubmed/?term=28730848
  8. Zheutlin A.B., Jeffries C.D., Perkins D.O., Chung Y., Chekroud A.M., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Seidman L.J., Walker E.F., Woods S.W., Tsuang M., Cannon T.D. (2017) The Role of microRNA Expression in Cortical Development During Conversion to Psychosis. Neuropsychopharmacology, 2017 Oct; 1-8 [Epub 2017 Feb 10]. PMID:28186095   https://www.ncbi.nlm.nih.gov/pubmed/?term=28186095
  9. Buchy L., Barbato M., Makowski C., Bray S., MacMaster F., Deighton S., Addington J. (2017) Mapping structural covariance networks of facial emotion recognition in early psychosis: A pilot study. Schizophrenia Research, 2017 Nov; 189:146-152 [Epub 2017 Feb 3]. PMID:28169088   https://www.ncbi.nlm.nih.gov/pubmed/?term=28169088
  10. Chung Y., Haut K., He G., van Erp T., McEwen S., Addington J., Bearden C., Cadenhead K., Cornblatt B., Mathalon D.H., McGlashan T., Perkins D., Seidman L.J., Tsuang M., Walker E., Woods S.W., Cannon T.D. (2017) Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis. Schizophrenia Research, 2017 Nov; 189:169-174 [Epub 2017 Feb 25]. PMID:28245961  https://www.ncbi.nlm.nih.gov/pubmed/?term=28245961
  11. Barbato M., Buchy L., McMaster F., Bray S., Deighton S., Addington J. (2017) Letter to the Editor: Testing the feasibility of a computerized facial affect recognition training in early psychosis. Schizophrenia Research, 2017 Dec; 190:180-181 [Epub 2017 Mar 9]. PMID:28285735   https://www.ncbi.nlm.nih.gov/pubmed/?term=28285735
  12. McAusland L., Buchy L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H., Addington J. (2017) Anxiety in youth at clinical high risk for psychosis. Early Intervention in Psychiatry, 2017 Dec; 11(6):480-487 [Epub 2015 Oct 12]. PMID:26456932   https://www.ncbi.nlm.nih.gov/pubmed/?term=26456932
  13. Addington J., Piskulic D., Liu L., Lockwood J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Bearden C.E., Mathalon D., Woods S.W. (2017) Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophrenia Research, 2017 Dec; 190:90-95 [Epub 2017 Mar 31]. PMID:28372906   https://www.ncbi.nlm.nih.gov/pubmed/?term=28372906
  14. Marshall C., Lu Y., Lyngberg K., Deighton S., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D., Addington J. (In Press) Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Intervention in Psychiatry, Epub 2017 Aug 3; PMID:28771938   https://www.ncbi.nlm.nih.gov/pubmed/?term=28771938
  15. Georgopoulos G., Stowkowy J., Liu L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H., Addington J. (In Press) The Role of a family history of psychosis for youth at clinical high risk of psychosis. Early Intervention in Psychiatry, Epub 2017 Aug 9; PMID:28792113   https://www.ncbi.nlm.nih.gov/pubmed/?term=28792113
  16. Lu Y., Marshall C., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D., Addington J. (2017) Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety. Psychiatry Research, 2017 Dec; 258:462-468 [Epub 2017 Aug 31]. PMID:28886901   https://www.ncbi.nlm.nih.gov/pubmed/?term=28886901

2016

  1. Fusar-Poli P., Schultze-Lutter F., Addington J. (2016) Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution. The Lancet Psychiatry, 2016 Jan 1; 3(1):18. PMID:26772061   https://www.ncbi.nlm.nih.gov/pubmed/?term=26772061
  2. Fusar-Poli P., Cappucciati M., Borgwardt S., Woods S.W., Addington J., Nelson B., Nieman D.H., Stahl D.R., Rutigliano G., Riecher-Rössler A., Simon A.E., Mizuno M., Lee T.Y., Kwon J.S., Lam M.M., Perez J., Keri S., Amminger P., Metzler S., Kawohl W., Rössler W., Lee J., Labad J., Ziermans T., An S.K., Liu C.C., Woodberry K.A., Braham A., Corcoran C., McGorry P., Yung A.R., McGuire P.K. (2016) Heterogeneity of Psychosis Risk within Individuals at Clinical High Risk: A Meta-analytical Stratification. JAMA Psychiatry, 2016 Feb; 1-8 [Epub 30 Dec 2015]. PMID:26719911   https://www.ncbi.nlm.nih.gov/pubmed/?term=26719911
  3. Stowkowy J., Liu L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D., Heinssen R., Addington J. (2016) Core Schemas in Youth at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy, 2016 Mar; 44(2):203-13 [Epub 2015 Apr 21]. PMID:25896713   https://www.ncbi.nlm.nih.gov/pubmed/?term=25896713
  4. Piskulic D., Liu L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H., Addington J. (2016) Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort. Schizophrenia Research, 2016 Mar; 171(1-3):176-81 [Epub 2016 Jan 16]. PMID:26785807   https://www.ncbi.nlm.nih.gov/pubmed/?term=26785807
  5. Drake R.J., Addington J., Viswanathan A.C., Lewis S.W., Cotter J., Yung A.R., Abel K.M. (2016) How age and gender predict illness course in a first-episode non-affective psychosis cohort. Journal of Clinical Psychiatry, 2016 Mar; 77(3):e283-9 [Epub 16 Feb 2016]. PMID:26890690   https://www.ncbi.nlm.nih.gov/pubmed/?term=26890690
  6. Kane J.M., Robinson D.G., Schooler N.R., Mueser K.T., Penn D.L., Rosenheck R.A., Addington J., Brunette M.F., Correll C.U., Estroff S.E., Marcy P., Robinson J., Meyer-Kalos P.S., Gottlieb J.D., Glynn S.M., Lynde D.W., Pipes R., Kurian B.T., Miller A.L., Azrin S.T., Goldstein A.B., Severe J.B., Lin H., Sint K.J., John M., Heinssen R.K. (2016) Comprehensive versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes from the NIMH RAISE Early Treatment Program. The American Journal of Psychiatry, 2016 Apr 1; 173(4):362-72 [Epub 2015 Oct 20]. PMID:26481174   https://www.ncbi.nlm.nih.gov/pubmed/?term=26481174
  7. Stowkowy J., Liu L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H. & Addington J. (2016) Early Traumatic Experiences, Perceived Discrimination and Conversion to Psychosis in those at Clinical High Risk for Psychosis. Social Psychiatry and Psychiatric Epidemiology, 2016 Apr; 51(4):497-503 [Epub 2016 Feb 6]. PMID:26851943   https://www.ncbi.nlm.nih.gov/pubmed/?term=26851943
  8. Stone W.S., Mesholam-Gately R.I., Giuliano A.J., Woodberry K.A., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan TH., Perkins D.O., Tsuang M.T., Walker E.F., Woods S.W., McCarley R.W., Heinssen R., Green M.F., Nuechterlein K., Seidman L.J. (2016) Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophrenia Research, 2016 Apr; 172(1-3):106-13 [Epub 2016 Feb 16]. PMID:26896388   https://www.ncbi.nlm.nih.gov/pubmed/?term=26896388
  9. Buchy L., Barbato M., MacMaster F.P., Bray S., Clark D., Deighton S., Addington J. (2016) Cognitive insight is associated with cortical thickness in first episode psychosis. Schizophrenia Research, 2016 Apr; 172(1-3):16-22 [Epub 2016 Feb 18]. PMID:26899212   https://www.ncbi.nlm.nih.gov/pubmed/?term=26899212
  10. Moskow D.M., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Heinssen R., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Cannon T.D., Woods S.W., Walker E.F. (2016) The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis. Schizophrenia Research, 2016 Apr; 172(1-3):29-34 [Epub 2016 Feb 20]. PMID:26905038   https://www.ncbi.nlm.nih.gov/pubmed/?term=26905038
  11. Fusar-Poli P., Schultze-Lutter F., Cappucciati M., Rutigliano G., Bonoldi I., Stahl D., Borgwardt S., Riecher-Rössler A., Addington J., Perkins D.O., Woods S.W., McGlashan T., Lee J., Klosterkötter J., Yung A.R., McGuire P. (2016) The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis. Schizophrenia Bulletin, 2016 May 1; 42(3):732-43 [Epub 2015 Nov 20]. PMID:26591006   https://www.ncbi.nlm.nih.gov/pubmed/?term=26591006
  12. Marulanda S. & Addington J. (2016) Resilience in Individuals at Clinical High Risk for Psychosis.  Early Intervention in Psychiatry, 2016 Jun; 10(3):212-9 [Epub 2014 Sep 18]. PMID:25234104   https://www.ncbi.nlm.nih.gov/pubmed/?term=25234104
  13. Rosenheck R., Leslie D., Sint K., Lin H., Robinson D.G., Schooler N.R., Mueser K.T., Penn D.L., Addington J., Brunette M.F., Correll C.U., Estroff S.E., Marcy P., Robinson J., Rupp A., Schoenbaum M., Kane J.M. (2016) Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program. Schizophrenia Bulletin, 2016 Jul 1; 42(4):896-906 [Epub 2016 Jan 31]. PMID:26834024   https://www.ncbi.nlm.nih.gov/pubmed/?term=26834024
  14. Deighton S., Buchy L., , Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H., Addington J. (2016) Traumatic Brain Injury in Individuals at Clinical High Risk for Psychosis. Schizophrenia Research, 2016 Jul; 174(1-3):77-81 [Epub 2016 May 7]. PMID:27165121   https://www.ncbi.nlm.nih.gov/pubmed/?term=27165121
  15. Marshall C., Deighton S., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D., Addington J. (2016) The Violent Content in Attenuated Psychotic Symptoms. Psychiatry Research, 2016 Aug 30; 242:61-66 [Epub 2016 May 7]. PMID:27259137   https://www.ncbi.nlm.nih.gov/pubmed/?term=27259137
  16. Buchy L., Mathalon D.H., Cannon T.D., Cadenhead K.S., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Addington J. (2016) Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis. Psychiatry Research, 2016 Aug 30; 254:3-9 [Epub 2016 Jun 2]. PMID:27289213   https://www.ncbi.nlm.nih.gov/pubmed/?term=27289213
  17. McLaughlin D., Carrión R.E., Auther A.M., Olvet D.M., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Heinssen R.K., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Goldberg T.E., Harvey P.D., Cornblatt B.A. (2016) Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. Schizophrenia Bulletin, 2016 Sep; 42(5):1234-42 [Epub 2016 Apr 22]. PMID:27105902   https://www.ncbi.nlm.nih.gov/pubmed/?term=27105902
  18. Cannon T.D., Yu C., Addington J., Bearden C.E., Cadenhead K.S., Cornblatt B.A., Heinssen R., Jeffries C.D., Mathalon D.H., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Kattan M.W. (2016) An Individualized Risk Calculator for Research in Prodromal Psychosis. American Journal of Psychiatry, 2016 Oct 1; 173(10):980-988 [Epub 2016 Jul 1]. PMID:27363508  https://www.ncbi.nlm.nih.gov/pubmed/?term=27363508
  19. Seidman L.J., Shapiro D.I., Stone W.S., Woodberry K.A., Ronzio A., Cornblatt B.A., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Mathalon D.H., McGlashan T.H., Perkins D.O., Tsuang M.T., Walker E.F., Woods S.W. (2016) Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry, 2016 Dec 1; 73(12):1239-1248. PMID:27806157   https://www.ncbi.nlm.nih.gov/pubmed/?term=27806157
  20. Jeffries C.D., Perkins D.O., Chandler S.D., Stark T., Yeo E., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D., McGlashan T.H., Seidman L.J., Walker E.F., Woods S.W., Glatt S.J., Tsuang M.T. (2016) Insights into Psychosis Risk from Leukocyte microRNA Expression. Translational Psychiatry, 2016 Dec 13; 6(12):e981. PMID:27959328   https://www.ncbi.nlm.nih.gov/pubmed/?term=27959328

2015

  1. Addington J., van der Gaag M. (2015) Psychosocial treatments for clinical high risk individuals Schizophrenia Bulletin, 2015 Jan 1; 41(1):22 [Epub 2014 Oct 14]. PMID:25316912   https://www.ncbi.nlm.nih.gov/pubmed/?term=25316912
  2. Cannon T.D., Chung Y., He G., Sun D., Jacobson A., van Erp T.G., McEwen S., Addington J., Bearden C.E., Cadenhead K., Cornblatt B., Mathalon D.H., McGlashan T., Perkins D., Jeffries C., Seidman L.J., Tsuang M., Walker E., Woods S.W., Heinssen R. (2015) North American Prodrome Longitudinal Study Consortium.  Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical riskSee comment in PubMed Commons below. Biological Psychiatry, 2015 Jan 15; 77(2):147-57 [Epub 2014 Jun 12]. PMID:25034946   https://www.ncbi.nlm.nih.gov/pubmed/?term=25034946
  3. Piskulic D., Barbato M., Liu L., Addington J. (2015) Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis. Psychiatry Research, 2015 Jan 30; 225(1-2):93-8 [Epub 2014 Nov 4]. PMID:25467705   https://www.ncbi.nlm.nih.gov/pubmed/?term=25467705
  4. Perkins D.O., Jeffries C.D., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Mathalon D.H., McGlashan T.H., Seidman L.J., Tsuang M,T., Walker E.F., Woods S.W., Heinssen R. (2015) Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophrenia Bulletin, 2015 Mar 1; 41(2):419-28 [Epub 2014 Aug 6]. PMID:25103207   https://www.ncbi.nlm.nih.gov/pubmed/?term=25103207
  5. Robinson D.G., Schooler N.R., John M., Correll C.U., Marcy P., Addington J., Brunette M.F., Estroff S.E., Mueser K.T., Penn D., Robinson J., Rosenheck R.A., Severe J., Goldstein A., Azrin S., Heinssen R., Kane J.M. (2015) Prescription Practices in the Treatment of First-Episode Schizophrenia Spectrum Disorders: Data from the National RAISE-ETP Study. American Journal of Psychiatry, 2015 Mar 1; 172(3):237-48 [Epub 2014 Dec 4]. PMID:25727536   https://www.ncbi.nlm.nih.gov/pubmed/?term=25727536
  6. Kane J.M., Schooler N.R., Marcy P., Correll C.U., Brunette M.F., Mueser K.T., Rosenheck R.A., Addington J., Estroff S.E., Robinson J., Penn D.L., Robinson D.G. (2015) The RAISE Early Treatment Program for first-episode psychosis: background, rationale and study design. Journal of Clinical Psychiatry, 2015 Mar; 76(3):240-6. PMID:25830446   https://www.ncbi.nlm.nih.gov/pubmed/?term=25830446
  7. Addington J., Liu L., Buchy L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H., McGlashan T.H. (2015) North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. The Journal of Nervous and Mental Disease, 2015 May; 203(5):328-35. PMID:25919383   https://www.ncbi.nlm.nih.gov/pubmed/?term=25919383
  8. Chung Y., Jacobson A., He G., van Erp T.G.M., McEwen S., Addington J., Bearden C.E., Cadenhead K., Cornblatt B., Mathalon D.H., McGlashan T., Perkins D., Seidman L.J., Tsuang M., Walker E., Woods S.W., Heinssen R., Cannon T.D. (2015). North American Prodrome Longitudinal Study (NAPLS) Consortium.  Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion among Clinically High-Risk Youth Developing Psychotic Disorders. Molecular Neuropsychiatry, 2015 May 1; 1(1):13-22. PMID:26005673   https://www.ncbi.nlm.nih.gov/pubmed/?term=26005673
  9. Auther A.M., Cadenhead K.S., Carrión R.E., Addington J., Bearden C.E., Cannon T.D., McGlashan T.H., Perkins D.O., Seidman L., Tsuang M., Walker E.F., Woods S.W., Cornblatt B.A. (2015) Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatrica Scandinavica, 2015 July; 132(1):60-8 [Epub 2015 Jan 9]. PMID:25572323   https://www.ncbi.nlm.nih.gov/pubmed/?term=25572323
  10. Addington J., Heinssen R.K., Robinson D.G., Schooler N.R., Marcy P., Brunette M.F., Correll C.U., Estroff S., Mueser K.T., Penn D., Robinson J.A., Rosenheck R.A., Azrin S.T., Goldstein A.B., Severe J., Kane J.M.  (2015) Duration of Untreated Psychosis in Community Treatment Settings in the United States. Psychiatric Services, 2015 July 1; 66(7):753-6 [Epub 2015 Jan 15]. PMID:25588418   https://www.ncbi.nlm.nih.gov/pubmed/?term=25588418
  11. Mueser K.T., Penn D.L., Addington J., Brunette M.F., Gingerich S., Glynn S.M., Lynde D.W., Gottlieb J.D., Meyer-Kalos P., McGurk S.R., Cather C., Saade S., Robinson D.G., Schooler N.R., Rosenheck R.A., Kane J.M. (2015) The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components Psychiatric Services, 2015 July1; 66(7):680-90 [Epub 2015 Mar 16]. PMID:25772766   https://www.ncbi.nlm.nih.gov/pubmed/?term=25772766
  12. Gee D.G., McEwen S.C., Forsyth J.K., Haut K.M., Bearden C.E., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Olvet D., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H., Tsuang M.T., van Erp T.G., Walker E.F., Hamann S., Woods S.W., Constable T., Cannon T.D. (2015) Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study. Human Brain Mapping, 2015 Jul; 36(7):2558-79 [Epub 2015 Mar 28]. PMID:25821147   https://www.ncbi.nlm.nih.gov/pubmed/?term=25821147
  13. Deighton S. & Addington J. (2015) Exercise practices in individuals at clinical high risk of developing psychosis. Early Intervention in Psychiatry, 2015 Aug; 9(4):284-91 [Epub 2013 Nov 20]. PMID:24252093   https://www.ncbi.nlm.nih.gov/pubmed/?term=24252093
  14. Buchy L., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R., Bearden C.E., Mathalon D., Addington J. (2015) Substance use in individuals at clinical high risk of psychosis. Psychological Medicine, 2015 Aug; 45(11):2275-84 [Epub 2015 Mar 2]. PMID: 25727300   https://www.ncbi.nlm.nih.gov/pubmed/?term=25727300
  15. Waford R.N., MacDonald A., Goines K., Novacek D.M., Trotman H.D., Elaine F.W., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Mathalon D.H., Tsuang M.T., Perkins D.O., Seidman L.J., Woods S.W., McGlashan T.H. (2015) Demographic correlates of attenuated positive psychotic symptoms. Schizophrenia Research, 2015 Aug; 166(1-3):31-6 [Epub 2015 May 18]. PMID:25999040   https://www.ncbi.nlm.nih.gov/pubmed/?term=25999040
  16. Anticevic A., Haut K., Murray J.D., Repovs G., Yang G.J., Cole M.W., McEwen S.C., Bearden C.D., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Olvet D., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H., Tsuang M.T., van Erp T.G.M., Walker E.F., Hamann S., Woods S.W., Qiu M., Cannon T.D. (2015) Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. JAMA Psychiatry, 2015 Sep 1; 72(9):882-91. PMID:26267151   https://www.ncbi.nlm.nih.gov/pubmed/?term=26267151
  17. Webb J.R., Addington J., Perkins D.O., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R.K., Seidman L.J., Tarbox S.I., Tsuang M.T., Walker E.F., McGlashan T.H., Woods S.W. (2015) Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis. Schizophrenia Bulletin, 2015 Sep 1; 41(5):1066-75. PMID:26272875   https://www.ncbi.nlm.nih.gov/pubmed/?term=26272875
  18. Buchy L., Stowkowy J., MacMaster F., Nyman K. & Addington J. (2015) Meta-cognition is associated with cortical thickness in youth at clinical high risk of psychosis. Psychiatry Research, 2015 Sep 30; 233(3):418-23 [Epub 2015 Jul 15]. PMID: 26210694   https://www.ncbi.nlm.nih.gov/pubmed/?term=26210694
  19. Barbato M., Liu L.,  Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E., Woods S.W., Bearden C.E., Mathalon D.H., Heinssen R. & Addington J. (2015) Theory of Mind, Emotion Recognition and Social Perception in Individuals at Clinical High Risk for Psychosis: findings from the NAPLS-2 cohort. Schizophrenia Research: Cognition 2, 2015 Sept; 2(3):133-39 [Epub 2015 May 16]. PMID:27695675   https://www.ncbi.nlm.nih.gov/pubmed/?term=27695675
  20. Addington J., Stowkowy J., Weiser M. (2015) Screening Tools for Clinical High Risk for Psychosis. Early Intervention in Psychiatry, 2015 Oct; 9(5):345-56 [Epub 2014 Oct 23]. PMID:25345316   https://www.ncbi.nlm.nih.gov/pubmed/?term=25345316
  21. Fusar-Poli P., Cappucciati M., Rutigliano G., Schultze-Lutter F., Bonoldi I., Borgwardt S., Riecher-Rössler A., Addington J., Perkins D., Woods S.W., McGlashan T.H., Lee J., Klosterkötter J., Yung A.R., McGuire P. (2015) At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry. 2015 Oct; 14(3):322-32 [Epub 2015 Sep 25]. PMID:26407788   https://www.ncbi.nlm.nih.gov/pubmed/?term=26407788
  22. Stowkowy J., Perkins D.O., Woods S.W., Nyman K., Addington J. (2015) Personal Beliefs about Experiences in those at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy, 2015 Nov; 43(6):669-75 [Epub 2014 Jun 20]. PMID:24949991   https://www.ncbi.nlm.nih.gov/pubmed/?term=24949991
  23. Zhang J.P., Robinson D.G., Gallego J.A., John M., Yu J., Addington J., Tohen M., Kane J.M., Malhotra A.K., Lencz T. (2015) Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis. Schizophrenia Bulletin, 2015 Nov 1; 41(6):1248-55 [Epub 2015 Aug 28]. PMID:26320194   https://www.ncbi.nlm.nih.gov/pubmed/?term=26320194
  24. Robinson D.G., Gallego J.A., John M., Petrides G., Hassoun Y., Zhang J.P., Lopez L., Braga R.J., Sevy S.M., Addington J., Kellner C.H., Tohen M., Naraine M., Bennett N., Greenberg J., Lencz T., Correll C.U., Kane J.M., Malhotra A.K. (2015) A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. Schizophrenia Bulletin, 2015 Nov 1; 41(6):1227-36 [Epub 2015 Sep 3]. PMID:26338693   https://www.ncbi.nlm.nih.gov/pubmed/?term=26338693
  25. Trampush J.W., Lencz T., DeRosse P., John M., Gallego J.A., Petrides G., Hassoun Y., Zhang J.P., Addington J., Kellner C.H., Tohen M., Burdick K.E., Goldberg T.E., Kane J.M., Robinson D.G., Malhotra A.K. (2015) Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders. Schizophrenia Bulletin, 2015 Nov 1; 41(6):1237-47 [Epub 2015 Sep 25]. PMID:26409223   https://www.ncbi.nlm.nih.gov/pubmed/?term=26409223
  26. Buchy L., Cannon T., Anticevic A., Lyngberg K., Cadenhead K.S., Cornblatt B.A., McGlashan T., Perkins D., Seidman L.,Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H., Addington J. (2015) Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. BMC Psychiatry, 2015 Nov 9; 15:276. PMID:26553191   https://www.ncbi.nlm.nih.gov/pubmed/?term=26553191
  27. Alderman T., Addington J., Bearden C., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Cadenhead K.S. (2015). Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Intervention Psychiatry, 2015 Dec; 9(6):467-75 [Epub 2014 Feb 27]. PMID: 24576057   https://www.ncbi.nlm.nih.gov/pubmed/?term=24576057
  28. Perkins D.O., Jeffries C.D., Cornblatt B.A., Woods S.W., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Heinssen R., Mathalon D.H., Seidman L.J., Tsuang M.T., Walker E.F., McGlashan T.H. (2015) Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophrenia Research, 2015 Dec; 169(1-3):169-77 [Epub 2015 Oct 4]. PMID:26441004   https://www.ncbi.nlm.nih.gov/pubmed/?term=26441004
  29. Lyngberg K., Buchy L., Liu L., Perkins D., Woods S., Addington J. Patterns of premorbid functioning in individuals at clinical high risk of psychosis. Schizophrenia Research, 2015 Dec; 169(1-3):209-13 [Epub 2015 Nov 14]. PMID:26589390   https://www.ncbi.nlm.nih.gov/pubmed/?term=26589390
  30. Buchy L., Seidman L.J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Stone W., Tsuang M.T., Walker E.F., Woods S.W., Bearden C.E., Mathalon D.H., Addington J. (2015) Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis. Psychiatry Research, 2015 Dec 30; 230(3):878-84 [Epub 2015 Nov 25]. PMID:26626949   https://www.ncbi.nlm.nih.gov/pubmed/?term=26626949
  31. Lyngberg K., Buchy L. & Addington J. (2015) Cognitive Insight in Youth at Clinical High Risk of Psychosis. JURA 2015, Vol.5

2014

  1. Cannon T.D., Sun F., McEwen S.J., Papademetris X., He G., van Erp T.G., Jacobson A., Bearden C.E., Walker E., Hu X., Zhou L., Seidman L.J., Thermenos H.W., Cornblatt B., Olvet D.M., Perkins D., Belger A., Cadenhead K., Tsuang M., Mirzakhanian H., Addington J., Frayne R., Woods S.W., McGlashan T.H., Constable R.T., Qiu M., Mathalon D.H., Thompson P., Toga A.W. (2014) Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. Human Brain Mapping, 2014 May; 35(5): 2424-34. PMID:23982962   http://www.ncbi.nlm.nih.gov/pubmed/?term=23982962
  2. Saleem M.M., Stowkowy J., Cadenhead K.S., Cannon T., Cornblatt B., McGlashan T., Perkins D., Seidman L., Tsuang M., Walker E., Woods S. & Addington J. (2014) Perceived Discrimination in those at Clinical High Risk for Psychosis. Early Intervention in Psychiatry,  2014 Feb; 8(1):77-81. PMID:23773288   http://www.ncbi.nlm.nih.gov/pubmed/?term=23773288
  3. Addington J., Case N., Saleem M.M., Auther A.M., Cornblatt B.A., Cadenhead K.S. (2014) Substance use in Clinical High Risk for psychosis – A review of the literature. Early Intervention in Psychiatry, 2014 May; 8(2):104-12. PMID:24224849   http://www.ncbi.nlm.nih.gov/pubmed/?term=24224849
  4. Meyer E.C., Carrión R.E., Cornblatt B.A., Addington J., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R., Seidman L.J., NAPLS Group (2014) The Relationship of Neurocognition and Negative Symptoms to Social and Role Functioning Over Time in Individuals at Clinical High Risk in the First Phase of the North American Prodrome Longitudinal Study. Schizophrenia Bulletin, 2014 Nov; 40(6):1452-61. PMID:24550526   http://www.ncbi.nlm.nih.gov/pubmed/?term=24550526
  5. Deighton S., Addington J. (2014) Exercise practices of young people at their first episode of psychosis. Schizophrenia Research, 2014 Jan; 152(1):311-2. PMID:24275584  http://www.ncbi.nlm.nih.gov/pubmed/?term=24275584
  6. Addington J., Shah H., Liu L., Addington D. (2014) Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis. Schizophrenia Research, 2014 Mar; 153(1-3):64-7. PMID:24439270   http://www.ncbi.nlm.nih.gov/pubmed/?term=24439270
  7. Lecomte T., Corbière M., Ehmann T., Addington J., Abdel-Baki A., MacEwan B. (2014) Development and Preliminary Validation of The First Episode Social Functioning Scale for Early Psychosis. Psychiatry Research, 2014 May 30; 216(3):412-7. PMID:24613006   http://www.ncbi.nlm.nih.gov/pubmed/?term=24613006
  8. Alderman T., Addington J., Bearden C., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Cadenhead K.S. (2014) Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Intervention Psychiatry, 2014 Feb 27; PMID:24576057 http://www.ncbi.nlm.nih.gov/pubmed/?term=24576057
  9. Yong E., Barbato M., Penn D.L., Keefe R.S.E., Woods S.W., Perkins D.O., Addington J. (2014) Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis. Psychiatry Research, 2014 Aug 15; 218(1-2):39-43. PMID:24755041 http://www.ncbi.nlm.nih.gov/pubmed/24755041
  10. Forsyth J.K., McEwen S.C., Gee D.G., Bearden C.E., Addington J., Goodyear B., Cadenhead K.S., Mirzakhanian H., Cornblatt B.A., Olvet D.M., Mathalon D.H., McGlashan T.H., Perkins D.O., Belger A., Seidman L.J., Thermenos H.W., Tsuang M.T., van Erp T.G., Walker E.F., Hamann S., Woods S.W., Qiu M., Cannon T.D. (2014) Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: Analysis from the North American Prodrome Longitudinal Study. Neuroimage, 2014 Aug 15; 97: 41-52. PMID:24736173   http://www.ncbi.nlm.nih.gov/pubmed/?term=24736173
  11. Miklowitz D.J., O'Brien M.P., Schlosser D.A., Addington J., Candan K.A., Marshall C.E., Domingues I., Walsh B.C., Zinberg J.L., De Silva S.D., Friedman-Yakoobian M.S., Cannon T.D. (2014) Family-Focused Treatment for Adolescents and Young Adults at High Risk for Psychosis: Results of a Randomized Trial. Journal of the American Academy of Child and Adolescent Psychiatry, 2014 Aug; 53(8): 848-58. PMID:25062592   http://www.ncbi.nlm.nih.gov/pubmed/?term=25062592
  12. Stowkowy J., Perkins D.O., Woods S.W., Nyman K., Addington J. (2014) Personal Beliefs about Experiences in those at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy, 2014 Jun 20:1-7. PMID:24949991   http://www.ncbi.nlm.nih.gov/pubmed/?term=24949991
  13. Correll C.U., Robinson D.G.,  Schooler N.R., Brunette M.F., Mueser K.T., Rosenheck R.A.,  Marcy P., Addington J., Estroff S.E., Robinson J., Penn D., Azrin S., Goldstein A., Severe J., Heinssen R., Kane J.M. (2014) Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatry, 2014 Dec 1; 71(12):1350-1363. PMID:25321337   http://www.ncbi.nlm.nih.gov/pubmed/?term=25321337
  14. Marshall C., Denny E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Addington J. (2014) The Content of Attenuated Psychotic Symptoms in Those at Clinical High Risk for Psychosis. Psychiatry Research, 2014 Nov 30; 219(3):506-12. PMID:25048759   http://www.ncbi.nlm.nih.gov/pubmed/?term=25048759
  15. Marulanda S., Addington J. (2014) Resilience in Individuals at Clinical High Risk for Psychosis. Early Intervention in Psychiatry, 2014 Sep 18. PMID:25234104   http://www.ncbi.nlm.nih.gov/pubmed/?term=25234104
  16. Woods S.W., Walsh B.C., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., Perkins D.O., Seidman L.J., Tarbox S.I., Tsuang M.T., Walker E.F., McGlashan T.H. (2014) Current Status Specifiers for Patients at Clinical High Risk for Psychosis. Schizophrenia Research, 2014 Sep; 158(1-3):69-75. PMID:25012147   http://www.ncbi.nlm.nih.gov/pubmed/?term=25012147
  17. Buchy L., Perkins D., Woods S.W., Liu L., Addington J. (2014) Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis. Schizophrenia Research, 2014 Jul; 156(2-3):277-80. PMID:24837058   http://www.ncbi.nlm.nih.gov/pubmed/?term=24837058
  18. Addington J., Stowkowy J., Weiser M. (2014) Screening Tools for Clinical High Risk for Psychosis. Early Intervention in Psychiatry, 2014 Oct 23. PMID:25345316   http://www.ncbi.nlm.nih.gov/pubmed/?term=25345316
  19. Callaway D.A., Perkins D.O., Woods S.W., Liu L. & Addington J. (2014) Movement abnormalities predict transitioning to psychosis in individuals at clinical high risk for psychosis. Schizophrenia Research, 2014 Nov; 159(2-3):263-6. PMID:25311779   http://www.ncbi.nlm.nih.gov/pubmed/?term=25311779
  20. Trotman H.D., Holtzman C.W., Walker E.F., Addington J., Bearden C.E., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R.K., Mathalon D.H., Tsuang T.T., Perkins D.O., Deidman L.J., Woods S.W., McGlashan T.H. (2014) Stress Exposure and Sensitivity in the Clinical High Risk Syndrome: Initial Findings from the North American Prodrome Longitundinal Study (NAPLS). Schizophrenia Research, 2014 Dec; 160(1-3):104-9. PMID:25443665   http://www.ncbi.nlm.nih.gov/pubmed/?term=25443665

2013

  1. Addington J. (2013) Identifying a treatable psychosis-risk cohort. Canadian Journal of Psychiatry, 2013 Jan; 58(1):3-4. PMID 23327749  http://www.ncbi.nlm.nih.gov/pubmed/?term=23327749
  2. Fusar-Poli P., Borgwardt S., Bechdolf A., Addington J., Riecher-Rössler A., Schultze-Lutter F. et al. (2013) The Psychosis High Risk State: A Comprehensive State-of-the-Art Review. JAMA Psychiatry, 2013 Jan; 70(1):107-20. PMID: 23165428  http://www.ncbi.nlm.nih.gov/pubmed/?term=23165428
  3. Magaud E., Nyman K. & Addington J. (2013) Cyberbullying in those at Clinical High Risk for psychosis. Early Intervention in Psychiatry, 2013 Nov; 7(4):427-30. PMID:23343259  http://www.ncbi.nlm.nih.gov/pubmed/?term=23343259
  4. Addington J., Stowkowy J., Cadenhead K.S., Cornblatt B.A., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W. & Cannon T.D. (2013)  Early traumatic experiences in those at clinical high risk for psychosis.  Early Intervention in Psychiatry, 2013 Aug; 7(3):300-5. PMID: 23343384 http://www.ncbi.nlm.nih.gov/pubmed/?term=23343384
  5. Suridjan I., Rusjan P., Addington J., Wilson A.A., Houle S. & Mizrahi R. (2013) Dopamine D2 and D3 binding in clinical high risk for schizophrenia, antipsychotic naïve and healthy controls while performing a cognitive task. Journal of Psychiatry and Neuroscience, Journal of Psychiatry and Neuroscience, 2013 Mar; 38(2):98-106. PMID: 23010256  http://www.ncbi.nlm.nih.gov/pubmed/?term=23010256
  6. Barbato M., Penn D.L., Perkins D.O., Woods S.W., Liu L. & Addington J. (2013) Metacognitive Functioning in Individuals at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy, 42(5):526-34. PMID: 23517866. http://www.ncbi.nlm.nih.gov/pubmed/?term=23517866
  7. Walder D., Holtzman C., Addington J., Cadenhead K., Tsuang M., Cornblatt B., Cannon T., McGlashan T., Woods S., Perkins D., Seidman L., Heinssen R. & Walker E.F. (2013) Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophrenia Research, 2013 Mar; 144(1-3):43-50. PMID: 23340377  http://www.ncbi.nlm.nih.gov/pubmed/?term=23340377
  8. Stowkowy J. & Addington J. (2013) Predictors of clinical high risk status among individuals with a family history of psychosis. Schizophrenia Research, 2013 Jul; 147(2-3):281-6. PMID: 23611242  http://www.ncbi.nlm.nih.gov/pubmed/?term=23611242
  9. Walker E.F., Trotman H.D., Pearce B.D., Addington J. ,Cadenhead K.S., Cornblatt B.A., Heinssen R., Mathalon D.H., Perkins D.O., Seidman L.J., Tsuang M.T., Cannon T.D., McGlashan T.H. & Woods S.W. (2013) Cortisol levels and risk for psychosis: Initial findings from the North American Prodrome Study. Biological Psychiatry, 2013 Sep 15; 74(6):410-7. PMID: 23562006 http://www.ncbi.nlm.nih.gov/pubmed/?term=23562006
  10. Barbato M., Colijn M.A., Keefe R.S., Perkins D.O., Woods S.W., Hawkins K.A., Christensen B.K. & Addington J. (2013) The course of cognitive functioning over six months in individuals at clinical high risk for psychosis. Psychiatry Research, 2013 Apr 30; 206(2-3):195-9. PMID: 23159196  http://www.ncbi.nlm.nih.gov/pubmed/?term=23159196
  11. Addington D., Patten S., McKenzie E. & Addington J. (2013) Relationship between Relapse and Hospitalization in First-Episode Psychosis. Psychiatric Services, 2013 Aug 1; 64(8):796-9. PMID: 23632466 http://www.ncbi.nlm.nih.gov/pubmed/?term=23632466
  12. Tarbox S.I., Addington J., Cadenhead S., Cannon T.D., Cornblatt B.A., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Heinssen R., McGlashan T.H. & Woods S.W. (2013) Premorbid functional development and conversion to psychosis in clinical high-risk youth. Development and Psychopathology 2013 Nov; 25(4 Pt 1):1171-86. PMID:24229556 http://www.ncbi.nlm.nih.gov/pubmed/?term=24229556
  13. Woods S., Addington J., Bearden C., Cadenhead K.S., Cannon T., Cornblatt B., Mathalon D.H., Perkins D., Seidman L., Tsuang M., Walker E. & McGlashan T. (2013) Psychotropic Medication Use in Youth at High Risk for Psychosis: Comparison of Baseline Data from Two Research Cohorts 1998-2005 and 2008-2011. Schizophrenia Research, 2013 Aug; 148(1-3):99-104 PMID: 23787224        http://www.ncbi.nlm.nih.gov/pubmed/?term=23787224
  14. Cadenhead K.S., Addington J., Cannon T., Cornblatt B., de la Fuente-Sandoval C., Mathalon D., Perkins D., Seidman L., Tsuang M., Walker E., Woods S., Bachman P., Belger A., Carrión R.E., Donkers F., Duncan E., Johannesen J., León-Ortiz P., Light G., Mondragón A., Niznikiewicz M., Nunag J., Roach B.J., Solís-Vivanco R. & the NAPLS Consortium (2013) Between Site Reliability of Startle Prepulse Inhibition Across Two Early Psychosis Consortia Running Head: Between Site Reliability of Startle PPI. NeuroReport,  2013 Aug 7; 24(11):626-30. PMID:23799460 http://www.ncbi.nlm.nih.gov/pubmed/?term=23799460
  15. Barbato M., Liu L., Penn D.L., Keefe R.S.E., Perkins D.O., Woods S.W. & Addington J. (2013) Social Cognition as a Mediator between Neurocognition and Functional Outcome in Individuals at Clinical High Risk for Psychosis. Schizophrenia Research, 2013 Nov; 150(2-3):542-6. PMID: 24012459  http://www.ncbi.nlm.nih.gov/pubmed/?term=24012459
  16. Deighton S., Addington J. (2013) Exercise practices in individuals at clinical high risk of developing psychosis. Early Intervention in Psychiatry, 9(4):284-91. PMID:24252093  http://www.ncbi.nlm.nih.gov/pubmed/?term=24252093
  17. Barbato M.Addington J. (2013) Binocular Depth Perception in Individuals at Clinical High Risk for Psychosis: no evidence of dysfunction. Neuropsychology, 28(3):366-72 PMID:24188117 http://www.ncbi.nlm.nih.gov/pubmed/?term=24188117
  18. Tarbox S. I., Addington J., Cadenhead K., Cannon T. D., Cornblatt B., Perkins D., Seidman L.J., Tsuang M. T., Walker E., Heinssen R., McGlashan T., Woods S. W. (2013) Functional Development in Clinical High Risk Youth: Prediction of Schizophrenia versus other Psychotic Disorders. Psychiatry Research, 215(1):52-60.  PMID: 24200216 http://www.ncbi.nlm.nih.gov/pubmed/?term=24200216
  19. Healey K.M., Penn D.L., Perkins D., Woods S.W., Addington J. (2013) Theory of mind and social judgments in people at clinical high risk of psychosis. Schizophrenia Research, 2013 Nov; 150(2-3):498-504. PMID: 24055202  http://www.ncbi.nlm.nih.gov/pubmed/?term=24055202

2012

  1. Stowkowy, J., Addington, D., Liu, L., Hollowell, B. & Addington, J. (2012) Predictors of   Disengagement from Treatment in an Early Psychosis Program. Schizophrenia Research, 136, 7-12. PMID: 22336955 http://www.ncbi.nlm.nih.gov/pubmed/?term=22336955
  2. Addington, J. & Lecomte, T. (2012) Cognitive Behavior Therapy for Psychosis. F1000 Medicine Reports, 4, 6. PMID: 22403587, PMCID: PMC3292287. http://www.ncbi.nlm.nih.gov/pubmed/?term=22403587
  3. Boydell, K., Volpe, T., Gladstone, B., Stasiulis, E. & Addington, J. (2012) Youth and Ultra High Risk for Psychosis, Using the Revised Network Episode Model to Examine Pathways to Mental Health Care. Early Intervention in Psychiatry, 7, 170-186. PMID: 22390350 http://www.ncbi.nlm.nih.gov/pubmed/?term=22390350
  4. Piskulic, D., Addington, J., Cadenhead, K., Cannon, T., Cornblatt, B., Heinssen, R., Perkins, D., Seidman, L., Tsuang, M., Walker, E., Woods, S., & McGlashan, T, (2012) Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Research, 196, 220-224. PMID: 22445704 http://www.ncbi.nlm.nih.gov/pubmed/?term=22445704
  5. Brummitt, K. & Addington, J. (2012) Treatment Possibilities for Individuals at Clinical High Risk of Psychosis.  Early Intervention in Psychiatry, 7, 155-161. PMID: 22741811  http://www.ncbi.nlm.nih.gov/pubmed/?term=22741811
  6. Stowkowy, J., Colijn, M. & Addington, J. (2012) Pathways to Care for those at Clinical High Risk of Developing Psychosis. Early Intervention in Psychiatry, 7, 80-83. PMID: 22741608  http://www.ncbi.nlm.nih.gov/pubmed/?term=22741608
  7. Marshall, C., Falukozi, E., Albertin, M., Zhu, H., & Addington, J. (2012). The development of the content of attenuated positive symptoms codebook for those at clinical high risk of psychosis. Psychosis: Psychological, Social and Integrative Approaches, 4,191-202.
  8. Addington, J., Piskulic, D., Perkins, D.O., Woods, S.W., Liu, L. & Penn, D.L. (2012) Affect Recognition in People at Clinical High Risk of Psychosis. Schizophrenia Research, 140, 87-92. PMID: 22763425 http://www.ncbi.nlm.nih.gov/pubmed/?term=22763425
  9. Addington, J., McGregor, L., Marulanda D., & Raedler, T. (2012) Recruitment strategies for the detection of individuals at clinical high risk of developing psychosis. Epidemiology and Psychiatric Sciences, 31,1-5. PMID: 23114021 http://www.ncbi.nlm.nih.gov/pubmed/?term=23114021
  10. Yung, A.R., Woods, S.W., Ruhrmann, S., Addington, J., Schultze-Lutter, F., Cornblatt, B.A. et al., (2012) Wither the attenuated psychosis syndrome? Schizophrenia Bulletin, 38, 1130-4. PMID: 23144056 http://www.ncbi.nlm.nih.gov/pubmed/?term=23144056
  11. Addington J. (2012) International Early Psychosis Association, Early Intervention in Psychiatry, 6, 355-6. PMID: 23107577 http://www.ncbi.nlm.nih.gov/pubmed/?term=23107577
  12. Addington, J., Cadenhead, K.S., Cornblatt, B.A, Mathalon, D.H., McGlashan, T.H., Perkins, D.O., Seidman, L.J., Tsuang, M.T., Walker, E.F., Woods, S.W., Addington, J.A. & Cannon, T.D. ( 2012) North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment. Schizophrenia Research, 142, 77-82. PMID: 23043872  http://www.ncbi.nlm.nih.gov/pubmed/?term=23043872
  13. Addington J., Marshall, C. & French P. (2012) Cognitive behavioral therapy in prodromal psychosis. Current Pharmaceutical Design, 18, 558-65. PMID: 22239588 http://www.ncbi.nlm.nih.gov/pubmed/?term=22239588
  14. Magaud, E. Marshall, C., Mancuso, E. & Addington, J. (2012). Use of the Self-Esteem Rating Scale—Short Form in a first episode of psychosis sample. Schizophrenia Research, 143, 399-400. PMID: 23265776  http://www.ncbi.nlm.nih.gov/pubmed/?term=23265776
  15. Barbato, M. & Addington, J. The role of cognitive functioning in the outcome of those at clinical high risk of psychosis (2012) Epidemiology and Psychiatric Sciences, 4), 335-42. PMID:23159196, PMCID: PMC3600156 http://www.ncbi.nlm.nih.gov/pubmed/?term=23159196
  16. Falukozi E. & Addington J. (2012) Impact of trauma on attenuated psychotic symptoms. Psychosis: Psychological, Social and Integrative Approaches, 2012; 4(3):203-212. PMID: 23155365 http://www.ncbi.nlm.nih.gov/pubmed/?term=23155365

2011

  1. Addington, J. & Piskulic, D. (2011). Social cognition and functional outcome are separate domains in schizophrenia. Schizophrenia Research, 127, 262-263. PMID: 20471225 http://www.ncbi.nlm.nih.gov/pubmed/?term=20471225
  2. Addington, J., Epstein, I., Liu, L., French, P., Boydell, K.M. & Zipursky, R.B. (2011).  A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophrenia Research, 125, 54-61, PMID: 21074974  http://www.ncbi.nlm.nih.gov/pubmed/?term=21074974
  3. Piskulic, D, & Addington, J., Arthur, A. & Cornblatt, B.A. (2011) Using the global functioning social and role scales in a first-episode sample. Early Intervention in Psychiatry, 5, 219-223, PMID: 21481198 http://www.ncbi.nlm.nih.gov/pubmed/?term=21481198
  4. Addington, J., Cornblatt, B., Cadenhead, K., Cannon, T., McGlashan, T., Perkins, D., Seidman, L Tsuang, M., Walker, E., Woods, S. &. Heinssen, R. (2011). At clinical high risk for psychosis: outcome for the non-converters. American Journal of Psychiatry, 168, 800-805. PMID: 21498462 http://www.ncbi.nlm.nih.gov/pubmed/?term=21498462
  5. Piskulic, D. & Addington, J. (2011). Social cognition and negative symptoms in psychosis. Psychiatric Research, 188, 283-285, PMID: 21571376 http://www.ncbi.nlm.nih.gov/pubmed/?term=21571376
  6. Menon, M., Addington, J. & Remington, G. (2011) Examining cognitive biases in patients with delusions of reference. European Psychiatry, 28:71-3. PMID:21658918 http://www.ncbi.nlm.nih.gov/pubmed/?term=21658918
  7. Stowkowy, J. & Addington, J. (2011). Maladaptive schemas as a mediator between social defeat and positive symptoms in young people at clinical high risk for psychosis. Early Intervention in Psychiatry, 168, 800-5. PMID:21951894 http://www.ncbi.nlm.nih.gov/pubmed/?term=21951894
  8. Marshall, C., Addington, J., Epstein, I., Liu, L., Deighton, S. & Zipursky, R.B. (2011) Treating Young Individuals at Clinical High Risk for Psychosis. Early Intervention in Psychiatry, 6, 60-8. PMID: 21951980 http://www.ncbi.nlm.nih.gov/pubmed/?term=21951980
  9. Gee, D.G., Karlsgodt, K.H., van Erp, T.G., Bearden, C.E., Lieberman, M.D., Belger, A., Perkins, D.O., Olvet, D.M., Cornblatt, B.A., Constable, T., Woods, S.W., Addington, J., Cadenhead, K.S., McGlashan, T.H., Seidman, L.J., Tsuang, M.T., Walker, E.F. & Cannon, T.D. (2011) Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study. Schizophrenia Research, 134, 1-9. PMID:  22056201  http://www.ncbi.nlm.nih.gov/pubmed/?term=22056201
  10. Cornblatt, B., Carrion, R.F.  Addington, J., Seidman, L., Walker, E., Cannon, T., Cadenhead, K., McGlashan, T., Perkins, D., Tsuang, M., Woods, S., Heinssen, R. & Lencz, T. (2011). Risk factors for psychosis: Impaired social and role functioning. Schizophrenia Bulletin, 38:1247-57.  PMID: 22080497  http://www.ncbi.nlm.nih.gov/pubmed/?term=22080497
  11. Mizrahi, R., Addington, J., Rusjan, P.M., Suridjan, I., Nq, A., Boileau, I., Pruessner, J.C., Remington, G., Houle, S. & Wilson, A.A. (2011). Increased stress-induced dopamine release in psychosis. Biological Psychiatry, 71, 561-567. PMID:22133268 http://www.ncbi.nlm.nih.gov/pubmed/?term=22133268
  12. Addington, J. & Heinssen, R. (2011) Prediction and prevention of psychosis in youth at clinical high risk. Annual Review of Clinical Psychology, 8, 269-289. PMID: 22224837  http://www.ncbi.nlm.nih.gov/pubmed/?term=22224837
  13. Menon, M., Schmitz, T.W., Anderson, A.K., Graff, A., Korostil, M., Mamo, D., Gerretsen, P., Addington, J., Remington, G. & Kapur, S. (2011) Exploring the neural correlates of delusions of reference. Biological Psychiatry, 70, 1127-33. PMID:21831358 http://www.ncbi.nlm.nih.gov/pubmed/?term=21831358

2010

  1. Addington, J., Piskulic, D., & Marshall, C. (2010). Psychosocial treatments for schizophrenia . Current Directions in Psychological Science, 19, 260-263.
    http://cdp.sagepub.com/content/19/4/260.full
  2. Cadenhead, K.S., Addington, J., Cannon, T.D., Cornblatt, B.A McGlashan, T., Perkins, D.O., Seidman. L., Tsuang, M.T., Walker, E.F., Woods, S., & Heinssen, R. (2010). Treatment history in the psychosis prodrome: Characteristics of the North American Prodrome Longitudinal Study Cohort. Early Intervention in Psychiatry, 4, 220-226.
    http://www.ncbi.nlm.nih.gov/pubmed/20712727
  3. Seidman. L., Giuliano, A.J., Meyer, A.C., Addington, J., Cadenhead, K.S., Cannon, T.D., McGlashan, T., Perkins, D.O., Tsuang, M.T., Walker, E.F., Woods, S., Bearden, C.E., Christensen, B.K., Hawkins, K., Heaton, R., Keefe, R.S.E., Heinssen, R., & Cornblatt, B.A. (2010). Neuropsychology of the prodrome to psychosis in the NAPLS consortium: Relationship to family history and conversion to psychosis. Archives of General Psychiatry, 67, 578-588.
    http://www.ncbi.nlm.nih.gov/sites/entrez/20530007
  4. Addington, J., Girard, T.A., Christensen, B.K., & Addington, D. (2010). Social cognition mediates illness related and cognitive influences on social functioning in schizophrenia-spectrum disorders. Journal of Psychiatry and Neuroscience, 35, 49-54.
    http://www.ncbi.nlm.nih.gov/sites/entrez/20530007
  5. McGorry, P., Johanessen, J.O., Lewis, S., Birchwood, M., Malla, A. Nordentoft, M., Addington, J., & Yung, A. (2010). Early intervention in psychosis: Keeping faith with evidence based health care. Psychological Medicine, 40, 399-404.
    http://www.ncbi.nlm.nih.gov/pubmed/19775497

2009

  1. Addington, J., & Addington, D. (2009). Three year outcome of treatment in an early psychosis program. Canadian Journal of Psychiatry, 54, 626-630.
    http://www.ncbi.nlm.nih.gov/pubmed/19751551
  2. Walker, E., Cornblatt, C., Addington, J., Cadenhead, K., Cannon, T.D., McGlashan, T.H., Perkins, D.O., Seidman, L.J., Tsuang, M., Woods, S.W., & Heinssen, R. (2009). The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: A naturalistic study of the North American Prodrome Longitudinal Sample. Schizophrenia Research, 115, 50-57.
    http://www.ncbi.nlm.nih.gov/pubmed/19709859
  3. Addington, J., & Mancuso, E. (2009). Cognitive-behavioral therapy for individuals at high risk of developing psychosis. Journal of Clinical Psychology, 65, 879-890.
    http://www.ncbi.nlm.nih.gov/pubmed/19536867
  4. Woods, S.W., Addington, J., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., Heinssen, R. Perkins, D.O., Seidman, L.J., Tsuang, M.T., Walker, E.F., & McGlashan, T.H. (2009). Prodromal risk syndrome for first psychosis. Schizophrenia Bulletin, 35, 894-908.
    http://www.ncbi.nlm.nih.gov/pubmed/19386578
  5. Addington, J., & Tran, L. (2009). Using the brief core schema scales with individuals at clinical high risk of psychosis. Behavioral and Cognitive Therapy, 37, 227-231.
    http://www.ncbi.nlm.nih.gov/pubmed/19364422

2008

  1. Addington, J., & Addington, D. (2008). Symptom remission in first episode patients. Schizophrenia Research, 106, 281-285.
    http://www.ncbi.nlm.nih.gov/pubmed/18926666
  2. Addington, J., & Addington, D. (2008). Outcome after discharge from an early psychosis program. Schizophrenia Research, 106, 363-366.
    http://www.ncbi.nlm.nih.gov/pubmed/18829260
  3. Hawkins, K.A., Keefe, R.S., Christensen, B.J., Addington, J., Woods, S.W., Callahan, J., Zipursky, R.B., Perkins, D.O., Tohen, M., Breier, A., & McGlashan, T.H. (2008). Neuropsychological course in the prodrome and first episode of psychosis: Findings from the PRIME North American Double Blind Treatment Study. Schizophrenia Research, 105, 1-9.
    http://www.ncbi.nlm.nih.gov/pubmed/18774696
  4. Pencer, A., & Addington, J. (2008). Models of substance use in adolescents with and without psychosis. Journal of the Canadian Academy of Child & Adolescent Psychiatry, 17, 202-209.
    http://www.ncbi.nlm.nih.gov/pubmed/19018323
  5. Compton, M.T., Goulding, S.M., Ramsay, C.E., Addington, J., Corcoran, C., & Walker, E. (2008). Early detection and intervention for psychosis: Perspectives from North America. Clinical Neuropsychiatry, 5, 263-272.
    http://www.clinicalneuropsychiatry.org/pdf/02_compton.pdf
  6. Mizrahi, R., Addington, J., Remington, G., & Kapur, S. (2008). Attribution style as a factor in psychosis and symptom resolution. Schizophrenia Research, 104, 220-227.
    http://www.ncbi.nlm.nih.gov/pubmed/18632256
  7. Addington. J., Epstein, I., Reynolds, A., Furimsky, I., Rudy, L., Mancini, B., McMillan, S., Kirsopp, D., & Zipursky, R.B. (2008). Early detection of psychosis: Finding those at clinical high risk. Early Intervention in Psychiatry, 2, 147-153.
    http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7893.2008.00078.x/abstract
  8. Weiser, M., Reichenberg, A., Werbeloff, N., Kravits, E., Halperin, D., Lubin, G., Shmushkevitch, M., Yoffe, R., Addington, J., Davidson, M. (2008). Self-report of family functioning and risk for psychotic disorders in male adolescents with behavioral disturbances. Acta Psychiatrica Scandinavica, 117, 225-231.
    http://www.ncbi.nlm.nih.gov/pubmed/18241305
  9. Couture, S.M., Penn, D.L., Addington, J., Woods, S.W., & Perkins, D.O. (2008). Assessment of social judgments and complex mental states in the early phases of psychosis. Schizophrenia Research, 100, 237-241.
    http://www.ncbi.nlm.nih.gov/pubmed/18255273
  10. Addington, J., Penn, D.L., Woods, S.W., Addington, D., & Perkins, D.O. (2008). Social functioning in individuals at clinical high risk for psychosis. Schizophrenia Research, 99, 119-124.
    http://www.ncbi.nlm.nih.gov/pubmed/18023329
  11. Addington, J., Penn, D.L., Woods, S.W., Addington, D., & Perkins, D.O. (2008). Facial affect recognition in individuals at clinical high risk for psychosis. British Journal of Psychiatry, 192, 67-68.
    http://www.ncbi.nlm.nih.gov/pubmed/18174514
  12. Cannon, T.D., Cadenhead, K., Cornblatt, C., Woods, S.W., Addington, J., Walker, E., Seidman, L.J., Perkins, D.O., Tsuang, M., McGlashan, T.H., & Heinssen, R. (2008). Prediction of psychosis in youth at clinical high risk: A multi-site longitudinal study in North America. Archives of General Psychiatry, 65, 28-37.
    http://www.ncbi.nlm.nih.gov/pubmed/18180426
  13. Addington J. & Addington, D.E. (2008). Social and cognitive functioning in psychosis. Schizophrenia Research, 99, 176-181.
    http://www.ncbi.nlm.nih.gov/pubmed/17681756
  14. Addington, J. (2008). The promise of early intervention. Early Intervention in Psychiatry, 1, 294-307.
    http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7893.2007.00043.x/abstract

2007

  1. Hoffman, R.E., Woods, S.W., Hawkins, K.A., Pittman, B., Tohen, M., Preda, A., Breier, A., Glist, J., Addington, J., Perkins, D.O., McGlashan, T.H. (2007). Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population. British Journal of Psychiatry, 191, 355-356.
    http://www.ncbi.nlm.nih.gov/pubmed/17906248
  2. Dutta, R., Greene, T., Addington, J., McKenzie, K., Phillips, M., & Murray, R.M. (2007). Biological, life course, and cross-cultural studies all point towards the value of dimensional and developmental ratings in the classification of psychosis. Schizophrenia Bulletin, 33, 868-876.
    http://www.ncbi.nlm.nih.gov/pubmed/17562692
  3. McCleery, A., Addington, J., & Addington, D. (2007). Family assessment in early psychosis. Psychiatry Research, 152, 95-102.
    http://www.ncbi.nlm.nih.gov/pubmed/17449111
  4. Addington, D., McKenzie, E., Addington, J., Patten, S., Smith H., & Adair, C. (2007). Performance measures for evaluating services for people with a first episode of psychosis. Early Intervention in Psychiatry, 1, 157-167.
    http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7893.2007.00020.x/full
  5. McGlashan, T.H., Addington, J., Cannon, T., Heinimaa, M., McGorry, P., O'Brien, M., Penn, D., Perkins, D., Salokangas, R.K., Walsh, B., Woods, S.W., & Yung, A. (2007). Recruitment and treatment practices for help-seeking "prodromal" patients. Schizophrenia Bulletin, 33, 715-726.
    http://www.ncbi.nlm.nih.gov/pubmed/17483100
  6. Addington, J., Mancuso, E., & Haarmans, M. (2007). Cognitive behaviour therapy and early intervention. The Journal of the Norwegian Psychological Association, 6, 573-580.
  7. Addington, J., Cadenhead, K.S. Cannon, T.D., Cornblatt, B., McGlashan, T.H., Perkins, D.O., Seidman, L.J., Tsuang, M., Walker, E.F., Woods, S.W., & Heinssen, R. (2007). North American Prodrome Longitudinal Study: A collaborative multi-site approach to prodromal schizophrenia research. Schizophrenia Bulletin, 33, 665-672.
    http://www.ncbi.nlm.nih.gov/pubmed/17255119
  8. Addington, J., & Addington, D. (2007). Patterns, predictors and impact of substance use in early psychosis: A longitudinal study. Acta Psychiatrica Scandinavica, 115, 304-309.
    http://www.ncbi.nlm.nih.gov/pubmed/17355521
  9. Saeedi, H., Addington, J., & Addington, D. (2007). The association of insight with psychotic symptoms, depression and cognition in early psychosis: A 3 year follow-up. Schizophrenia Research, 89, 123-128. http://www.ncbi.nlm.nih.gov/pubmed/17097272

2006

  1. Addington, D., Addington, J., and Patten, S. (2006). Relapse Rates in an Early Psychosis Treatment Service. Acta Psychiatrica Scandinavica, 115, 126-131.
    http://www.ncbi.nlm.nih.gov/pubmed/17244176
  2. McCleery, A., Addington, J., & Addington D. (2006). Substance misuse and cognitive functioning in early psychosis: A 2 year follow-up. Schizophrenia Research, 88, 187-191.
    http://www.ncbi.nlm.nih.gov/pubmed/16942863
  3. Pierson, K., Addington, D., Addington, J., & Patten, S. (2006). Serum Monitoring in Antipsychotic Drug Levels During Concomitant Administration of Sertraline and Antipsychotic Medication. Canadian Journal of Psychiatry, 51, 715-718.
    http://www.ncbi.nlm.nih.gov/pubmed/17121171
  4. Addington, J., Saeedi, H., & Addington, D. (2006). Weight gain in early psychosis over three years. Schizophrenia Research, 86, 335-336.
    http://www.ncbi.nlm.nih.gov/pubmed/16887336
  5. Addington, J., Saeedi, H., & Addington, D. (2006). Influence of social perception and social knowledge on cognitive and social functioning in early psychosis. British Journal of Psychiatry, 189, 373-378.
    http://www.ncbi.nlm.nih.gov/pubmed/17012662
  6. Chaves, A.C., Addington, J., Seeman, M. & Addington, D. (2006). One year stability of diagnosis in first episode non-affective psychosis: Influence of sex. Canadian Journal of Psychiatry, 51, 711-714.
    http://www.ncbi.nlm.nih.gov/pubmed/17121170
  7. Addington, J., Chaves, A.C., & Addington, D. (2006). Diagnostic stability over one year in first-episode psychosis. Schizophrenia Research, 86, 71-75.
    http://www.ncbi.nlm.nih.gov/pubmed/16750610
  8. Addington, J., Saeedi, H., & Addington, D. (2006). Facial affect recognition: A mediator between cognitive and social functioning in psychosis? Schizophrenia Research, 85, 142-150.
    http://www.ncbi.nlm.nih.gov/pubmed/16678388
  9. Addington, J., & Addington, D. (2006). Early intervention for psychosis: who refers? Schizophrenia Research, 84, 176-177.
    http://www.ncbi.nlm.nih.gov/pubmed/16546354
  10. McGlashan, T.H., Zipursky, R.B., Perkins, D., Addington, J., Miller, T., Woods, S., Hawkins, K., Hoffman, R., Preda, A., Epstein, I., Addington, D., Lindborg, S., Trzaskoma, Q., Tohen, M., & Breier, A. (2006). The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: Efficacy and safety results of the bouble-blind and no-treatment follow-up periods. American Journal of Psychiatry, 163, 790-799.
    http://www.ncbi.nlm.nih.gov/pubmed/16648318
  11. Addington, J., & Haarmans, M. (2006). Cognitive-behavioural therapy for individuals recovering from a first episode of psychosis. Contemporary Psychotherapy, 36, 43-49.
    http://www.springerlink.com/content/v37035m445n64751/
  12. Addington, J., McCleery, A., Collins, A., & Addington, D. (2006). Family work in early psychosis. Journal of Family Psychotherapy, 17, 137-153.
    http://www.informaworld.com/smpp/content~db=all~content=a902889756

2005

  1. Addington, D., McKenzie, E., Addington, J., Patten, S., Smith H., & Adair, C. (2005). Performance measures for early psychosis treatment services. Psychiatric Services, 56, 1570-1582.
    http://www.ncbi.nlm.nih.gov/pubmed/16339620
  2. Addington, J., McCleery, A., & Addington, D. (2005). Three year outcome of family work in an early psychosis program. Schizophrenia Research, 79, 107-116.
    http://www.ncbi.nlm.nih.gov/pubmed/15907375
  3. Addington, J., Collins, A., McCleery, A., & Addington, D. (2005). The role of family work in early psychosis. Schizophrenia Research, 79, 77-83.
    http://www.ncbi.nlm.nih.gov/pubmed/16198240
  4. Addington, J. (2005). 4th International Conference on Early Psychosis: 'Translating the evidence'. Schizophrenia Research, 79, 1-4.
  5. Addington, J., Saeedi, H., & Addington, D. (2005). The course of cognitive functioning in first episode psychosis: Changes over time and impact on outcome. Schizophrenia Research, 78, 35-43.
    http://www.ncbi.nlm.nih.gov/pubmed/15978781
  6. Addington, J., & Gleeson, J. (2005). Implementing cognitive-behavioural therapy for first-episode psychosis. British Journal of Psychiatry, 187 (Suppl. 48), 72-276.
    http://www.ncbi.nlm.nih.gov/pubmed/16055812
  7. Addington, J., & Addington, D. (2005). Clinical trials in the prodromal stage of schizophrenia psychosis: Who consents? [Letter to the editor]. American Journal of Psychiatry, 162, 1387.
    http://www.ncbi.nlm.nih.gov/pubmed/15994732
  8. Voges, M., & Addington, J. (2005). The association between social anxiety and social functioning in first episode psychosis. Schizophrenia Research, 76, 287-292.
    http://www.ncbi.nlm.nih.gov/pubmed/15949660
  9. Addington, J., & Addington, D. (2005). Patterns of premorbid functioning in first episode psychosis: Relationship to 2-year outcome. Acta Psychiatrica Scandinavica, 112, 40-46.
    http://www.ncbi.nlm.nih.gov/pubmed/15952944
  10. Pencer A., Addington, J., & Addington D. (2005). Outcome of a first episode of psychosis in adolescence: A 2-year follow-up. Psychiatry Research, 133, 35-43.
    http://www.ncbi.nlm.nih.gov/pubmed/15698675

2004

  1. Van Mastrigt, S., Addington, J., & Addington, D. (2004). Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology, 39, 69-72.
  2. Mintz, A.R., Addington, J., & Addington D. (2004). Insight in early psychosis: A one year follow-up. Schizophrenia Research, 67, 213-217.
  3. Hawkins, K.A., Quinlan, D., Miller, T.J., Woods, S.W., Perkins, D.O., Zipursky, R.B., Addington, J., & McGlashan, T.H. (2004). Factorial structure of the scale of prodromal symptoms. Schizophrenia Research, 68, 339-347.
  4. Hawkins, K.A., Addington, J., Keefe, R.S., Christensen, B., Perkins, D.O., Zipursky, R., Woods, S.W., Miller, T.J., Narqueez, E., Breier, A., & McGlashan, T.H. (2004). Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophrenia Research, 67,115-122.
  5. Addington, J., Williams, J., Young, J. & Addington, D. (2004). Suicidal behaviour in early psychosis. Acta Psychiatrica Scandinavica, 109, 116-120.
  6. Addington, J., Van Mastrigt, S., & Addington, D. (2004). Duration of untreated psychosis: Impact on one and two year outcome. Psychological Medicine, 34, 277-284.
  7. Addington, J. (2004). The diagnosis and assessment of individuals prodromal for schizophrenic psychosis. CNS Spectrum, 9, 588-594.

2003

  1. Woods, S.W., Breier, A., Zipursky, R.B., Perkins, D.O., Addington, J., Miller, T.J., Hawkins, K.A., Marquez, E., David, S.R., Tohen, M., & McGlashan, T.H. (2003). Randomized trial of olanzapine versus placebo in the symptomatic treatment of patients meeting criteria for the schizophrenic prodrome. Biological Psychiatry, 54, 453-464.
  2. Quillams, L., & Addington, J. (2003). Beliefs about illness, insight and knowledge in first episode psychosis [Letter to the Editor]. Canadian Journal of Psychiatry, 48, 350.
  3. Pencer, A., & Addington, J. (2003). Substance abuse and cognition in early psychosis. The Journal of Psychiatry & Neuroscience, 28, 48-54.
  4. Miller, T.J., Zipursky, R.B., Perkins, D.O., Addington, J., Woods, S.W., Hawkins, K.A., Hoffman, R., David, S., Tohen, M., Breier, A., & McGlashan, T.H. (2003). A randomized double blind clinical trial of olanzapine versus placebo in patients at risk for being prodromally symptomatic for psychosis: II. Recruitment and baseline characteristics of the prodromal sample. Schizophrenia Research, 61, 19-30.
  5. McGlashan, T.H., Zipursky, R.B., Perkins, D.O., Addington, J., Miller, T.J., Woods, S.W., Hawkins, K.A., Hoffman, R., David, S., Tohen, M., & Breier, A. (2003). A randomized double blind clinical trial of olanzapine versus placebo in patients at risk for being prodromally symptomatic for psychosis: I. Study rationale and design. Schizophrenia Research, 61, 7-18.
  6. Addington, J., Young, J. & Addington, D. (2003). Social outcome in early psychosis program. Psychological Medicine, 33, 1119-1124.
  7. Addington, J., van Mastrigt, S., & Addington D. (2003). Patterns of premorbid functioning in first episode psychosis: Initial presentation. Schizophrenia Research, 62, 23-30.
  8. Addington, J., Mansley, C., & Addington, D. (2003). Weight gain in early psychosis. Canadian Journal of Psychiatry, 48, 272-276.
  9. Addington, J., Leriger, E., & Addington, D. (2003). Symptom outcome one year after admission to an early psychosis program. The Canadian Journal of Psychiatry, 48, 204-207.
  10. Addington J., Coldham, E., Jones, B., Ko, T., & Addington, D. (2003). The first episode of psychosis: The experience of relatives. Acta Psychiatrica Scandinavica, 108, 285-289.

2002

  1. Addington, J. Brooks, B., & Addington, D. (2002). Cognitive functioning in first episode psychosis: Initial presentation. Schizophrenia Research, 62, 59-64.
  2. Van Mastrigt, S., & Addington, J. (2002). The assessment of premorbid functioning in first episode schizophrenia. The Journal of Psychiatry & Neuroscience, 27, 92-101.
  3. Coldham, E.L., Addington, J., & Addington, D. (2002). Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica, 106, 286-290.
  4. Addington, J., van Mastrigt, S., Hutchinson, J., & Addington D. (2002). Pathways to Care: Help seeking behavior in first episode psychosis. Acta Psychiatrica Scandinavica, 106, 358-364.
  5. Addington, J., & Addington, D. (2002). Cognitive functioning in first episode schizophrenia. The Journal of Psychiatry & Neuroscience, 27, 188-192.
  6. Addington, D., Addington, J., Patten, S., Remington, G., Moamai, J., Labelle, A., & Beauclair, L. (2002). Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. Journal of Clinical Psychopharmacology, 22, 20-25.

2001

  1. Martens, L., & Addington, J. (2001). Psychological well being of family members of individuals with schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 36, 128-133.
  2. Grant, C., Addington, J., Addington, D., & Konnert, C. (2001). Social functioning in first & multi-episode schizophrenia. Canadian Journal of Psychiatry, 46, 669-672.
  3. Addington J., Jones, B., Ko, T., & Addington, D. (2001). Family intervention in early psychosis. Psychiatric Rehabilitation Skills, 5, 272-286.
  4. Addington, J., Addington, D., & Gasbarre, L. (2001). Neurocognitive and social functioning in schizophrenia and other diagnoses [Letter to the Editor]. Schizophrenia Research, 48, 367-368.
  5. Addington, J., & Addington, D. (2001). Impact of an early psychosis program on substance use. The Journal of Psychiatric Rehabilitation, 25, 60-67.
  6. Addington, J., & Addington, D. (2001). Impact of an early psychosis program on substance use. The Journal of Psychiatric Rehabilitation, 25, 60-67.
  7. Addington, J., & Addington, D. (2001). Early intervention for psychosis: The Calgary Early Psychosis Treatment & Prevention Program. The Canadian Psychiatric Association Bulletin, 33, 11-16.
  8. Addington, D., & Addington, J. (2001). Depression in schizophrenia. Journal of Advances in Schizophrenia, 3, 121-125.

2000

  1. Addington, J., & Addington, D. (2000). Neurocognitive and social functioning in schizophrenia: A 2.5 year follow-up. Schizophrenia Research, 44, 47-56.

1999

  1. Addington J., el-Guebaly, N., Duchak, V., & Hodgins, D. (1999). Using measures of readiness to change in individuals with schizophrenia. Journal of Drug and Alcohol Abuse, 25, 151-161.
  2. Addington, J., & Addington D. (1999). Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin, 25,173-182.
  3. Addington, D., Addington, J., & Robinson, G. (1999). Attributional style and depression in schizophrenia. Canadian Journal of Psychiatry, 44, 697-700.

1998

  1. Addington, J., McCleary, L., & Munroe-Blum, H. (1998). Cognitive and social dysfunction in schizophrenia. Schizophrenia Research, 34, 59-66.
  2. Addington, J., el-Guebaly, N., Addington, D., Campbell, W., & Hodgins, D. (1998). Smoking cessation treatment in schizophrenia. American Journal of Psychiatry, 55, 974-976.
  3. Addington, J., & el-Guebaly, N. (1998). Group treatment for substance abuse in schizophrenia. Canadian Journal of Psychiatry, 43, 843-845.
  4. Addington, J., & Addington D. (1998). Visual attention & symptoms in schizophrenia: A one year follow-up. Schizophrenia Research, 34, 95-99.
  5. Addington, J., & Addington, D. (1998). The effects of substance abuse in early psychosis. British Journal of Psychiatry, 172 (Suppl. 33), 134-136.
  6. Addington, J., & Addington, D. (1998). Facial affect recognition and information processing in schizophrenia and bipolar disorder. Schizophrenia Research, 32, 171-181.
  7. Addington, J. (1998). Group treatment for smoking cessation in schizophrenia. Psychiatric Services, 49, 925-928.
  8. Addington, D., Addington, J., & Patten, S. (1998). Depression in first episode schizophrenia. British Journal of Psychiatry, 172 (Suppl. 33), 90-92.

1997

  1. Addington, J., el-Guebaly, N., Addington, D., & Hodgins, D. (1997). Readiness to stop smoking in schizophrenia. Canadian Journal of Psychiatry, 42, 49-52.
  2. Addington, J., & Duchak, V. (1997). Reasons for substance use in schizophrenia. Acta Psychiatrica Scandinavica, 96, 329-333.
  3. Addington, J., & Addington, D. (1997). Substance abuse and cognitive functioning in schizophrenia. The Journal of Psychiatry & Neuroscience, 22, 99-104.
  4. Addington, J., & Addington, D. (1997). Neurocognitive functioning in schizophrenia: A trial of risperidone versus haloperidol [Letter to the Editor]. The Canadian Journal of Psychiatry, 42, 983.
  5. Addington, J., & Addington, D. (1997). Attentional vulnerability indicators in schizophrenia and bipolar disorder. Schizophrenia Research, 23, 197-204.

1996

  1. Addington, J., & el-Guebaly, N. (1996). Intravenous tripelennamine abuse in schizophrenia [Letter to the Editor]. The Canadian Journal of Psychiatry, 41, 63.
  2. Addington, D., Addington, J., & Patten, S. (1996). Gender and affect in schizophrenia. Canadian Journal of Psychiatry, 41, 265-268.
  3. Addington, D., Addington, J., & Atkinson, M. (1996). A psychometric comparison of the Calgary Depression Scale for Schizophrenia. Schizophrenia Research, 19, 205-212.

1994

  1. Addington, D., Addington, J., & Maticka-Tyndale, E. (1994). Specificity of the Calgary Depression Scale for schizophrenics. Schizophrenia Research, 11, 239-244.

1993

  1. Addington, J., & Addington, D. (1993). Premorbid functioning, cognitive functioning and outcome in schizophrenia. The Journal of Psychiatry & Neuroscience, 18, 18-23.
  2. Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Rating depression in schizophrenia: A comparison of self-report and an observer report scale. Journal of Nervous and Mental Disease, 181, 561-565.
  3. Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Assessing depression in schizophrenia: The Calgary Depression Scale. British Journal of Psychiatry, 163 (Suppl. 22), 39-44.

1992

  1. Addington, D., Addington, J., Joyce, J. & Maticka-Tyndale, E. (1992). Reliability and validity of a depression rating scale. Schizophrenia Research, 6, 201-208.
  2. Addington, D., Addington, J., Joyce, J., & Maticka-Tyndale, E. (1992). Reliability and validity of a depression rating scale. Schizophrenia Research, 6, 201-208.

1991

  1. Addington, J., Addington, D., & Maticka-Tyndale, E. (1991). Cognitive functioning and positive and negative symptoms of schizophrenia. Schizophrenia Research, 5, 123-134.
  2. Addington, J., & Addington, D. (1991). Positive and negative symptoms of schizophrenia: Their course and relationship over time. Schizophrenia Research, 5, 51-59.

1990

  1. Addington, D., Addington, J., & Schissel, B. (1990). A depression rating scale for schizophrenics. Schizophrenia Research, 3, 247-251.
  2. Addington, D., & Addington, J. (1990). Depression, negative symptoms, and dexamethasone suppression in schizophrenia. Canadian Journal of Psychiatry, 35, 430-433.